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ABSTRACT 
 
To examine mutual interactions between key mediators of inflammation and circadian 
clocks and their role in diet-induced metabolic disorders, we first determined whether 
circadian rhythm desynchronization exacerbates high fat diet (HFD)-induced 
proinflammatory and metabolic responses. In mice exposed to shifted light-dark (LD) 
cycles, the disrupted entrainment of circadian behavior and modulation of peripheral clock 
function was accompanied by further amplification of HFD-induced adipose tissue 
macrophage infiltration, proinflammatory M1 activation and cytokine expression along 
with corresponding increases in the severity of insulin resistance and glucose intolerance. 
Feedback modulation of circadian clock by diet-induced inflammatory signaling was next 
examined by determining whether HFD and different fatty acids alter fundamental 
properties of circadian behavior and peripheral clock gene rhythms in conjunction with 
their proinflammatory effects. The anti-inflammatory, polyunsaturated fatty acid, 
docosahexaenoic acid (DHA), had negligible effects on circadian rhythms. However, 
prolonged treatment with HFD or palmitate, the prevalent proinflammatory saturated fatty 
acid (SFA) in HFD, modulated suprachiasmatic nucleus (SCN)-regulated behavioral 
rhythmicity and peripheral clock gene rhythms, inducing small increases in free-running 
period of the activity rhythm and substantial lengthening (3-9hr) of the period of clock 
gene rhythms in macrophages, fibroblasts and differentiated adipocytes. Following acute 
treatment, palmitate had little or no effect on the phase of the activity rhythm but induced 
time-dependent phase shifts of clock gene rhythms in cultured fibroblasts and 
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differentiated adipocytes. The time-dependent phase shifting effects of acute palmitate 
were contemporaneous with rhythmic changes in palmitate-induced inflammatory 
signaling (NF-κB and IL-6). DHA and other inhibitors of inflammatory signaling 
repressed palmitate-induced proinflammatory responses and phase shifts of the fibroblast 
clock. Acute treatment with the proinflammatory cytokine IL-6 mimicked the peak phase 
shifting effects of palmitate alone and blockade of TNFα signaling using a neutralizing 
antibody repressed palmitate-induced phase shifts, suggesting that SFA-mediated 
inflammatory signaling via these proinflammatory cytokines may feed back to modulate 
circadian timekeeping in peripheral clocks. These findings suggest that key mediators of 
inflammation and inflammatory signaling may play a role in the mechanism by which 
HFD and SFAs modulate clock timekeeping properties, and in turn this dysregulation of 
circadian clocks exacerbates diet-induced systemic insulin resistance and glucose 
intolerance. 
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CHAPTER I  
INTRODUCTION 
 
Circadian Rhythms 
 The earth rotates on its own axis once every 24 hours resulting in a daily cycle of day 
and night. Throughout evolution, in response to predictable changes in the environment 
on the rotating earth, rhythmicity has become a common property of many biological 
processes in living organisms including cyanobacteria, fungi, plants and animals. In 
particular, biological processes in these organisms fluctuate rhythmically so as to closely 
follow the daily solar cycle, and thus allow living organisms to anticipate and prepare in 
advance for predictable changes in the external environment.  
 These 24-hour rhythms are observed in some prokaryotic and almost all eukaryotic 
organisms. For example, the most primitive organism, cyanobacteria, has a daily rhythm 
in photosynthesis and nitrogen fixation, which peak during daytime and nighttime, 
respectively. The filamentous fungus Neurospora crassa is characterized by rhythmic 
production of conidiospores (Correa and Bell-Pedersen, 2002). In addition, Drosophila 
melanogaster displays robust rhythmicity in locomotor activity (Klarsfeld et al., 2003).  
 Similar to simple model systems, mammals exhibit daily rhythms in a wide array of 
biochemical, physiological and behavioral processes. The sleep-wake cycle is a prominent 
example of daily rhythmicity in mammals. Diurnal animals show a consolidated 8-12 hour 
interval of sleep at night and wakefulness during the daytime. Nocturnal animals show an 
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opposite pattern: sleep during the daytime and activity at night. The sleep-wake cycle is 
associated with other rhythmic biological processes such as body temperature and 
melatonin secretion (Wyatt et al., 1999). Body temperature peaks during the active period 
and remains low during sleep. Melatonin secretion from the pineal gland increases prior 
to sleep, reaches peak levels around midnight and declines before wakefulness in humans. 
Furthermore, other physiological and behavioral processes such as food intake, locomotor 
activity, and immune responses are marked by 24-hour rhythmicity in mammals 
(Scheiermann et al., 2013; Vollmers et al., 2009).  
 
Fundamental Properties of Circadian Rhythms 
From unicellular and multicellular organisms, rhythmic processes that oscillate with 
periods of approximately 24 hours are referred to as circadian (derived from Latin ‘circa’ 
and ‘diēm’ meaning ‘about’ and a ‘day”) rhythms. Circadian rhythms are distinguished by 
three fundamental properties:  
1) Rhythmic processes persist in the absence of environmental time cues (e.g., 
solar cycle) with a period of about 24 hours. Under constant conditions, circadian rhythms 
“free-run,” with a period, τ (tau), close to, but not exactly, 24 hours, indicating their 
endogenous regulation by an internal biological clock. For example, the circadian rhythm 
of mouse wheel-running activity persists in a constant darkness (DD) with a free-running 
period (FRP) of 23.5 hours (i.e., activity onsets occur 0.5 hour earlier each day). ; 
2) Circadian rhythms are synchronized or entrained by environmental cycles with 
periods ranging from about 21-26 hours. In mammals, the daily solar or light-dark (LD) 
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cycle and other environmental stimuli such as food availability, temperature, humidity, 
and social cues are ‘zeitgebers’ (German term for ‘time givers’) that mediate the 
entrainment of circadian rhythms. During steady-state entrainment, circadian rhythms 
assume not only the exact periodicity of the external cycle, but also adopt a particular and 
characteristic phase relationship to environmental time cues (e.g., daily onset of rodent 
activity rhythm occurs shortly after lights-off during LD entrainment); and  
3) Circadian rhythms are temperature compensated such that their endogenous 
periodicity remains fairly stable over a range of physiological temperatures. The rates for 
most biochemical and physiological processes are temperature-dependent and typically 
vary 2-3 fold (i.e., Q10 value of 2-3) with every 10º change in temperature. By comparison, 
temperature-induced modulation of circadian rhythms is much lower; the free-running 
period of circadian rhythms changes by only 2-3 hours with every 10º variation in 
temperature (i.e., Q10 ≈ 1.1). 
 
Functional Organization of Circadian System 
Circadian rhythms are regulated by internal biological clocks. Even though the core 
clock mechanism differs among species, the basic functional organization of the circadian 
time keeping system is well-conserved in all living organisms and consists of three main 
components: clock or oscillator, sensory input/entrainment pathways and circadian output 
pathways. The oscillator is a pacemaker that generates circadian rhythms. Sensory 
input/entrainment pathways convey external time cues (e.g., light-dark information, food 
availability) that mediate the synchronization of the oscillator to environmental cycles. 
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Lastly, output pathways from the circadian clock are responsible for the regulation of overt 
rhythms in various molecular, cellular and behavioral processes, which reflect the “hands” 
of the clock.  
 
Molecular Mechanism for Circadian Timekeeping in Mammals 
The circadian timekeeping mechanism consists of interlocked transcription-translation 
feedback loops. In mammals, Brain, muscle ARNT-like protein 1 (Bmal1), circadian 
locomotor output cycles kaput (Clock), as well as the Period (Per1 and Per2) and 
Cryptochrome (Cry) genes form the “gears” of the molecular clockworks that mediate 
circadian timekeeping throughout the body. These molecular components interact through 
positive- and negative-feedback loops in which gene transcription is rhythmically 
regulated by their protein products (Takahashi et al., 2008). In the positive arm, the helix-
loop-helix transcription factors BMAL1 and CLOCK form heterodimers that up-regulate 
Per and Cry transcription by binding on E-box elements in the promoter region. 
Accumulated PER and CRY in cytoplasm then translocate to the nucleus and down-
regulate their own transcription by inhibiting BMAL1-CLOCK transcriptional activity. In 
ancillary loops of the molecular clockworks, BMAL1-CLOCK heterodimers initiate 
transcription of the orphan nuclear receptors, Rev-erbα and Rorα. In turn, REV-ERBα and 
RORα bind to retinoic acid-related orphan receptor response elements (ROREs) present 
in Bmal1 promoter, leading respectively to the repression and activation of Bmal1 
transcription. 
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Hierarchical Structure of Mammalian Circadian Clocks 
The molecular feedback loops comprising the mammalian circadian clockworks are 
common to virtually all cells throughout the body and these cell-autonomous clocks are 
hierarchically organized. The ensemble of cellular clocks in the suprachiasmatic nucleus 
(SCN) of the hypothalamus functions as a master pacemaker in this hierarchical network 
and mediates the temporal synchronization of clocks located in other brain regions and 
peripheral tissues. In turn, these “peripheral” clocks provide for the local coordination of 
tissue- or cell-specific processes in time. 
 
SCN pacemaker: The SCN is located dorsal to the optic chiasm near the third ventricle 
in the anterior hypothalamus and consists of bilaterally paired structures containing 
approximately 20,000 neurons. The pacemaker function of the SCN was initially 
established through ablation studies demonstrating that complete lesions of this structure 
abolish overt circadian rhythms in many different processes including locomotor activity, 
feeding and body temperature (Moore and Eichler, 1972; Stephan and Zucker, 1972). 
However, conclusive evidence for the unique role of the SCN as a circadian pacemaker 
function was derived from observations indicating that fetal transplants of the SCN restore 
circadian behavioral rhythmicity in SCN-lesioned hosts (Lehman et al., 1987; Silver et al., 
1990). Another important functional property of the SCN is that its cells are capable of 
generating self-sustained oscillations in various molecular and physiological processes 
including cellular metabolism, neuropeptide secretion, electrical activity, and gene 
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expression. Furthermore, the SCN communicates temporal information via diffusible 
factors to peripheral circadian clocks throughout the body. 
 
Peripheral clocks: Virtually all peripheral tissues and cells throughout the body 
contain self-sustained and cell-autonomous clocks similar to those in the SCN. For 
example, explanted tissues from mPer2luc knock-in mice show persistent Per2::Luc 
rhythms in liver, muscle and adipose tissue in vitro (Yoo et al., 2004b). In addition, cell-
autonomous clocks in the SCN and peripheral tissues share the same molecular 
mechanism responsible for their circadian timekeeping function. However, overt circadian 
rhythms regulated by the SCN or peripheral clocks are entrained by different signals. 
 
Regulation of Circadian Clocks 
The daily LD cycle is the predominant environmental signal that entrains SCN-
regulated circadian rhythms such as the activity and body temperature rhythms. The SCN 
receives direct retinal innervation via the retinohypothalamic track (RHT), a 
monosynaptic projection from a subpopulation of retinal ganglion cells that contain the 
photopigment, melanopsin, and terminate bilaterally in the ventrolateral subregions of 
each nucleus. The RHT is necessary for circadian photoentrainment because transection 
of this visual pathway disrupts circadian entrainment to LD cycles without affecting 
image-forming visual functions.  
Although the principal zeitgeber in mammals is the daily solar cycle, other non-photic 
environmental stimuli that oscillate daily, such as food availability, also play a role in the 
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entrainment of circadian rhythms, especially in light-insensitive peripheral clocks. Under 
conditions of continuous food availability, the SCN mediates the LD entrainment of 
peripheral clocks presumably through neural and humoral signals. However, restricted 
feeding schedules in conjunction with a regular LD cycle overrides SCN control and 
directly entrains peripheral clocks. In rodents, restricted feeding at a fixed time of day acts 
as an independent zeitgeber and entrains a distinct bout of activity that precedes the daily 
onset of food availability. For example, rats maintained on a restricted feeding schedule 
during the light phase of a standard LD 12:12 cycle show entrainment of food anticipatory 
activity (FAA) during the daytime along with LD-synchronized nocturnal activity in 
which daily onsets occur near lights-off (Mistlberger, 1994). Even during exposure to 
constant conditions, FAA entrainment to restricted feeding cycles persists whereas LD-
entrainable activity free-runs with a circadian periodicity. Critical evidence for the role of 
food availability as a circadian zeitgeber is derived from observations indicating that FAA 
entrainment to restricted feeding schedules only occurs within a limited range when the 
period of the schedules is greater than 22 hours but less than 31 hours (Stephan, 1981). 
Importantly, the effects of restricted feeding schedules are mediated by a SCN-
independent circadian oscillator or food-entrainable oscillator (FEO) because FAA 
entrainment persists following SCN lesions that abolish the circadian rhythm of light-
entrainable activity (Krieger et al., 1977; Phillips and Mikulka, 1979).  
Food-mediated entrainment of behavioral rhythmicity is accompanied by modulation 
of clock gene rhythms in peripheral tissues. Similar to the effects of a light pulse during 
the subjective night, restricted feeding during the daytime, but not nighttime, phase shifts 
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clock gene oscillations (e.g. Per and Cry). It is noteworthy that food-induced phase shifts 
occur more rapidly in the metabolically-active tissues such as the liver relative to those 
observed in heart and kidney (Damiola et al., 2000). However, restricted feeding cycles 
do not affect the molecular clockworks in the SCN (Stokkan et al., 2001), but differentially 
affect the phase and amplitude of clock gene rhythms in some brain regions (Verwey and 
Amir, 2011). 
Nutrient availability also modulates circadian outputs such as rhythmic hormone 
release from peripheral tissues. For example, restricted feeding cycles shift the phase and 
increase the amplitude of the circadian rhythm in serum insulin levels (Rubin et al., 1988). 
In addition, daytime restricted feeding shifts the diurnal melatonin rhythm in the rat 
(Challet et al., 1997). The precise mechanism by which restricted feeding cycles modulate 
circadian rhythms is unknown, but these studies provided initial evidence for interactions 
between nutrient intake and circadian clock that may underscore the implications of 
circadian rhythm disruption in metabolic disorders. 
 
Impact of Nutrient Metabolism on Circadian Clock  
Consistent with the entraining effects of restricted feeding cycles, dietary composition 
and nutrient metabolism alter fundamental properties of circadian behavioral rhythms and 
the underlying molecular clockworks.   
 
Effects of high fat diet: High fat diet (HFD) has been shown to alter the circadian 
rhythm of wheel-running activity in mice such that the free-running period is increased 
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relative to animals fed a regular chow diet (Kohsaka et al., 2007a). Importantly, a small 
increase in the free-running period of the activity rhythm occurred immediately following 
the onset of the HFD treatment. HFD-fed mice also exhibited damped diurnal rhythms of 
feeding and locomotor behavior due to relative increases in food intake and total activity 
during the daytime. These data indicate that the systemic regulation of circadian behavior 
is modulated by dietary composition.  
Since overt circadian behavior provides a reflection of the functional status of the core 
clock mechanism, it is not surprising that diet has a compatible impact on the molecular 
oscillations comprising clock feedback loops. In conjunction with its effects on circadian 
behavior, HFD altered clock gene oscillations in peripheral tissues (Kohsaka et al., 2007a). 
In HFD-fed mice, the amplitude of diurnal rhythms in Clock, Bmal1, Per Rev-erbα and 
Rorα mRNA was attenuated in liver and fat, but not in the SCN, after 6 weeks of treatment, 
indicating that dietary composition alters the molecular clock mechanism in tissue-specific 
manner.  
The effects of HFD on circadian clock properties are not limited to changes in rhythm 
period and amplitude, but include differential shifts in the phase of clock gene oscillations 
in specific tissues. (Pendergast et al., 2013). HFD treatment for 7 days shifts the phase of 
the Per2 rhythm in mice, inducing large advances in the liver and small delays in the 
spleen. However, HFD has no effect on the phase of Per2 rhythm in the SCN. These diet-
induced alterations in the phase control of circadian clocks in peripheral tissues mediating 
nutrient processing may represent contributing factors in the development of metabolic 
disorders.  
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Effects of fatty Acids: Because fatty acids are the primary components distinguishing 
HFD and LFD, it will be necessary to differentiate the circadian effects of SFAs and 
polyunsaturated fatty acids due to their mutually antagonistic actions on inflammatory and 
metabolic signaling pathways. Palmitate is the most common SFA in animals, and dietary 
consumption of processed and fast foods is a major source of this putative 
proinflammatory fatty acid. Despite the well-characterized effects of palmitate on 
proinflammatory signaling and downstream metabolic processes, evidence for its impact 
on the molecular clockworks is limited to the finding that palmitate decreases the 
amplitude of the rhythms in Per2 and Rev-erb mRNA expression in a hypothalamic cell 
line (Fick et al., 2011). Similarly, few studies have explored the influence of 
polyunsaturated fatty acids on circadian rhythms. In hamsters fed a polyunsaturated fatty 
acid-deficient diet, the nocturnal peak in pineal melatonin levels was attenuated relative 
to that observed in controls (Lavialle et al., 2008). These data suggest that the relative 
content of saturated and polyunsaturated fatty acids may determine how HFD modulates 
circadian clock properties. 
 
Effects of glucose: In addition to fatty acids, other nutrients such as glucose have a 
modulatory influence on the molecular clockworks.  For instance, a low concentration of 
glucose in growth medium increases circadian period and decreases the amplitude of the 
rhythm in Bmal1 expression in cultured mouse fibroblasts (Lamia et al., 2009). 
Furthermore, modulation of O-GlcNAcylation in the hexosamine biosynthetic pathway 
that mediates nutrient sensing through glucose alters the period of clock gene rhythms 
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(Kaasik et al., 2013; Li et al., 2013). Collectively, these data suggest that glucose sensing 
and metabolism may feedback to regulate the circadian clock machinery.  
 
Effects of metabolic hormones: Consistent with its modulation by specific nutrients 
such as glucose and fatty acids, fundamental properties of the clock mechanism are 
affected by humoral factors that mediate metabolic homeostasis and inflammatory 
responses. In streptozotocin-induced insulin-deficient diabetic rats, the rhythms of Per, 
Cry, Bmal1, Rev-erb, and Ror mRNA expression in liver are phase advanced relative to 
controls, and insulin treatment induces time-dependent phase shifts in the rhythm of Dbp 
mRNA levels in the liver (Yamajuku et al., 2012). In addition, leptin modulates the light-
induced phase shifts of the circadian rhythm in mouse wheel-running activity such that 
pre-treatment with leptin amplifies the phase-advancing effects of light pulses 
administered during the late subjective night (Mendoza et al., 2011). Consistent with this 
modulation of light-induced phase shifts in circadian behavior, leptin treatment also 
potentiates the photic induction of Per1 and Per2 mRNA expression in the SCN during 
the late subjective night.  
 
Effects of inflammatory response: Nutrient-induced inflammatory responses also 
modulate circadian timekeeping. For example, prostaglandin E2, a pro-inflammatory 
compound derived from unsaturated cyclic fatty acids, has phase-resetting actions on 
peripheral clocks in vivo (Tsuchiya et al., 2005). Injections of prostaglandin E2 induce 
time-dependent shifts in the phase of the Per1 mRNA rhythms in mouse liver, kidney and 
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heart, with advances during the early day and delays during the early night. Thus, dietary 
modulation of the circadian system is determined by the integrated influence of specific 
nutrients and humoral factors regulating metabolic processes and inflammatory responses. 
  
Circadian Regulation of Nutrient Metabolism 
The circadian system plays an important role in maintaining energy homeostasis 
through the regulation of many different physiological processes related to nutrient 
metabolism.  
 
Feeding cycle: The initial stage of clock involvement in energy homeostasis begins 
with circadian control of feeding cycles. In anticipation of daily changes in food 
availability (and susceptibility to predation), animal feeding behavior is rhythmically 
regulated such that food intake primarily occurs during the day in diurnal species and 
during the night in nocturnal species. The rhythm in feeding behavior is regulated by the 
circadian clock because complete lesions of the SCN abolish diurnal oscillations of food 
and water intake ((Nagai et al., 1978; Stephan and Zucker, 1972). Furthermore, genetic 
knockout or mutation of core clock genes also alters circadian rhythms of food intake. For 
example, both Bmal1-/-- and Cry1/Cry2-/--deficient mice are characterized by the loss of 
feeding rhythms (Iijima et al., 2005; Storch and Weitz, 2009). In addition, Clock mutant 
mice also exhibit attenuated rhythm in feeding behavior due to hyperphagia (Pitts et al., 
2003; Turek et al., 2005). Interestingly, all of these clock mutant or knockout mice show 
similar evidence of metabolic disorders in conjunction with the loss of rhythms in feeding 
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behavior. These data indicate that clock control of daily mealtimes is critical for its 
function in the regulation of energy homeostasis. 
 
Fatty acid metabolism: In addition to the timing of feeding behavior, circadian 
regulation of nutrient composition and quantity also has a major impact on energy 
homeostasis. Several studies indicate that the circadian clock regulates metabolism at 
many different levels, thus producing daily fluctuations of nutrient levels in peripheral 
tissues. In this way, free fatty acids in the serum fluctuate on a daily basis, with peak levels 
during the middle of the daytime (ZT6) (Shostak et al., 2013). However, ClockΔ19 mutant 
and Bmal1-/--deficient mice are distinguished by low and arrhythmic free fatty acid content 
in the blood (Shostak et al., 2013), again suggesting that the rhythmic modulation of 
lipolysis rates and corresponding release of free fatty acids may be critical for clock 
function in the regulation of energy homeostasis. The precise modulation of free fatty acid 
levels through clock-controlled regulation of triglyceride hydrolysis is critical because 
excessive fatty acids can induce lipotoxicity or inflammation in peripheral tissues (Unger 
et al., 2010). 
The circadian regulation of fatty acid metabolism including lipolysis and lipogenesis 
is largely mediated through the rhythmic expression or activation of enzymes in peripheral 
tissues. For example, the levels of fatty acids during nighttime fasting in diurnal animals 
are high due to increased lipolysis. Consistent with this observation, transcripts encoding 
lipolytic enzymes such as adipose triglyceride lipase (Atgl) and hormone sensitive lipase 
(Hsl) exhibit circadian oscillations with a peak at circadian time (CT)12 in adipose tissue 
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that are abolished in ClockΔ19 and Bmal1 knockout mice (Shostak et al., 2013). In addition, 
Acyl CoA synthetase (Acsl1) mRNA, which is responsible for fatty acids biosynthesis, 
fluctuates rhythmically in adipose tissue peaking around CT6, and the phase of this rhythm 
is shifted by 12 hours in ClockΔ19 mice (Shostak et al., 2013). Along with lysis and 
synthesis of nutrients, absorption is another regulatory mechanism that is critical for 
maintaining energy homeostasis in the body. Caveolin-2 is an important protein in fatty 
acid transport, and transcripts encoding this gene exhibit circadian variation with peak 
expression at CT12 in mouse adipose tissue. These studies indicate that the circadian 
regulation of metabolic enzymes and transport proteins is congruent with clock control of 
fatty acid metabolism. 
 
Glucose metabolism: The circadian clock also regulates various aspects of glucose 
metabolism in the mammals. Circadian variation is evident in plasma glucose levels, 
which peak during the daytime, and this oscillation is abolished in Clock mutant mice 
(Rudic et al., 2004). Furthermore, glucose tolerance responses, which reflect uptake of 
glucose, oscillate with a maximum during the nighttime and SCN ablation abolishes this 
diurnal rhythm by enhancing glucose tolerance during the daytime (la Fleur et al., 2001; 
Rubin et al., 1988). Diurnal oscillations in the physiological levels of glucose are a 
corollary of clock control of gluconeogenesis and glycolysis. Consistent with this 
observation, a key rate-limiting enzyme of gluconeogenesis, phosphoenolpyruvate 
carboxykinase (PEPCK), fluctuates on a daily basis in liver and aorta, and this diurnal 
rhythm was disrupted in Clock mutant mice (Rudic et al., 2004). Moreover, the conversion 
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of exogenous pyruvate to glucose, which provides an index of gluconeogenesis, was also 
greatly impaired in Bmal1-deficient (Bmal1-/-) mice, indicating that clock disruption 
affects normal glucose metabolism. Because insulin is the principal regulator of glucose 
metabolism, circadian modulation of insulin release from pancreas beta cells is 
fundamental to clock function in maintaining energy homeostasis. The diurnal rhythm in 
plasma insulin concentration in rats is marked by a gradual increase near the end of the 
day and peak levels early in the night near the onset of activity (Yamamoto et al., 1987). 
SCN lesions eliminate this rhythmic variation in insulin secretion and hence the plasma 
glucose rhythm such that concentrations remain at basal levels. In addition to the circadian 
regulation of hormone secretion, insulin sensitivity varies during the daily cycle, with 
injections decreasing plasma glucose levels more rapidly during the nighttime or active 
phase than during the day (la Fleur et al., 2001).  
 
Other metabolic enzymes: Many metabolism-associated enzymes are clock-regulated. 
For example, the enzymatic activity of sirtuin, a NAD+-dependent histone deacetylase that 
acts as a sensor of energy availability and modulates metabolism, fluctuates rhythmically 
in mouse liver with peak levels during the night (Bellet et al., 2011). Importantly, sirtuin 
also mutually interacts with other circadian-regulated metabolic enzymes, including 
peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and 
AMPK to maintain energy homeostasis (Bellet et al., 2011). PGC-1α activates 
gluconeogenic gene transcription, but inhibits glycolytic gene transcription in the liver. In 
addition, PGC-1α stimulates mitochondrial biogenesis, which in turn promotes beta-
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oxidation of fatty acids so as to reduce intracellular levels of fatty acids. PGC-1α 
expression in mouse liver and skeletal muscle exhibits diurnal rhythmicity with peak 
levels during the nighttime (Liu et al., 2007). AMPK is a nutrient sensing protein that 
increases beta-oxidation of fatty acids through PCG-1α-mediated mitochondria biogenesis 
and inhibits acetyl-CoA carboxylase, thus decreasing fatty acid production. AMPK mRNA 
expression and AMPK phosphorylation in mouse liver are marked by circadian rhythms 
that peak during the subjective day (Lamia et al., 2009). Consistent with these 
observations, we have observed circadian regulation of AMPK phosphorylation in mouse 
fibroblasts and this rhythm is abolished in fibroblasts with targeted disruption of Per1 and 
Per2. In addition, microarray studies indicate that circadian gene expression in mouse 
fibroblasts is more prevalent among genes that regulate energetic processes such as 
glucose metabolism, mitochondrial energy transduction, lipid and fatty acid metabolism 
(e.g., stearoyl-coenzyme A desaturase 1 [Scd1], long chain fatty acyl CoA synthase [Facl], 
fatty acid synthase [Fasn]), and transporters of energy metabolites (Menger et al., 2007). 
Collectively, these observations indicate that circadian clock regulation of metabolic 
enzymes is important in the maintenance of energy homeostasis in peripheral tissues.  
 
Metabolites: Nutrient metabolism ultimately yields various metabolites, many of 
which oscillate on a circadian basis and depend on circadian clock function. Generally, 
the levels of amino acid metabolites are increased during the nighttime whereas 
carbohydrate, lipid, and nucleotide metabolites are increased during the daytime in 
nocturnal animals (Eckel-Mahan et al., 2012). In addition, the nucleotide metabolite, 
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nicotinamide adenine dinucleotide (NAD+), is rhythmically expressed in mouse liver. 
Since NAD+ is reduced to NADH during glycolysis, NAD+ levels in the liver of fasted 
mice are elevated during the rest period, peaking near the middle of the subjective day 
(Peek et al., 2013). In ad lib-fed mice, NAD+ exhibits a bimodal rhythm in liver with peaks 
in the middle of the day and middle of the night (Ramsey et al., 2009). In addition, 
nicotinamide phosphoribosyltransferase (NAMPT) mediates the NAD+ oscillation 
because NAMPT directly regulates NAD+ biosynthesis and its bimodal pattern in the liver 
is similar to that of NAD+ (Ramsey et al., 2009). Importantly, both of these oscillations 
are clock-controlled because ClockΔ19, Bmal1-/- or Cry1/Cry2-/- mutant mice display 
altered levels and/or arrhythmic profiles of NAMPT and NAD+ in the liver (Nakahata et 
al., 2009; Ramsey et al., 2009). AMP is another rhythmically regulated nucleotide 
metabolite that is the byproduct of ATP degradation in response to energy demand. Similar 
to NAD+, AMP levels in mouse liver are high during the day and low throughout the night 
(Eckel-Mahan et al., 2012). Cellular content of ATP fluctuates on a circadian basis in the 
rat SCN such that rhythmic levels peak during the middle of the subjective night 
(Yamazaki et al., 1994). Extracellular ATP accumulation similarly exhibits circadian 
oscillations in rat SCN in vivo and in vitro, with peak levels occurring during the latter 
half of the night (Womac et al., 2009). Furthermore, cAMP, a derivative of ATP, also 
oscillates in rat SCN with bimodal peaks during the late subjective day and late subjective 
night (Prosser and Gillette, 1991). These metabolites function as cofactors for various 
transcription factors and enzymes, therefore the circadian regulation of these metabolites 
is important to maintain energy homeostasis in peripheral tissues.  
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Humoral factors: In conjunction with other processes regulating nutrient metabolism, 
the release of humoral factors plays a key role in fine-tuning energy homeostasis. 
Circadian oscillations in humoral factors such as adipokines contribute to the regulation 
of feeding cycles and nutrient metabolism by rhythmically modulating satiety or hunger. 
Adiponectin and leptin are two crucial adipokines released from adipose tissue in response 
to changes in systemic metabolic status. Adiponectin increases food intake whereas leptin 
has the converse effect. Interestingly, the peaks of circadian rhythms in serum levels of 
both adiponectin and leptin occur during the nighttime in rats. However, plasma levels of 
leptin are arrhythmic and constantly increased even during the daytime in ClockΔ19 mice 
indicating that clock disruption causes metabolic disorders such as hyperleptinemia (Turek 
et al., 2005). In addition, hormones mediating local or systemic inflammation are 
associated with nutrient metabolism, especially in response to over-nutrition or high-fat 
diet. Recent evidence indicates that circadian clocks in peripheral tissues play an integral 
role in linking inflammatory and metabolic responses. 
 
Inflammatory response: Like other peripheral cells and tissues throughout the body, 
immune cells, including macrophages, B- and T-cells, contain cell-autonomous clocks 
(Keller et al., 2009). These endogenous clocks in immune cells provide for the circadian 
control of their abundance in the circulation, production of inflammatory factors, and 
functional responses to inflammatory challenge. For example, the circadian clock 
mediates the rhythmic regulation of: 1) the number of circulating immune cells in blood; 
2) NF-κB, a key mediator of immune responses that modulates the expression of target 
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inflammatory genes (Bozek et al., 2009); 3) macrophage expression of toll-like receptor 
(TLR) 4 that regulates innate immunity and lipopolysaccharide (LPS) responsiveness; and 
4) LPS-induced TNF-α and IL-6 release by macrophages (Keller et al., 2009).  
Importantly, the rhythmic regulation of immune system physiology and function is 
controlled by the circadian clock mechanism. For example, the circadian regulation of 
leukocyte abundance in the circulation is abolished in Clock mutant mice (Oishi et al., 
2003; Oishi et al., 2006). In addition, disruption or deletion of Per2 abolishes the daily 
rhythms in serum levels of the proinflammatory cytokine IFN-γ and the rhythm in 
susceptibility to LPS-induced inflammatory death (Arjona and Sarkar, 2006; Liu et al., 
2006). Similarly, the circadian rhythm in TLR9 expression is altered in peritoneal 
macrophages from Per2 mutant mice (Silver et al., 2012).  
Thus, there is substantial evidence indicating that the circadian clock directly or 
indirectly regulates many different metabolic processes involved in the maintenance of 
energy homeostasis. 
 
Disruption of the Circadian Clock and Metabolic Disorders 
Over-nutrition has long been considered as the main cause of alterations in energy 
homeostasis that lead to metabolic disorders. However, recent studies suggest that 
dysregulation of circadian clock function may contribute to metabolic disorders based on 
their increased incidence in shift workers and individuals experiencing sleep loss or 
maintaining nocturnal lifestyles (Buxton et al., 2012). For example, shift work is 
associated with high levels of triglycerides and low levels of high-density lipoproteins in 
 20 
 
the plasma, and elevated blood pressure, all of which are indicative of metabolic disorders 
(Karlsson et al., 2003). Shift-workers are also distinguished by increased risk of diabetes 
(Morikawa et al., 2005) and metabolic syndrome (obesity, high triglycerides, and low 
concentrations of HDL cholesterol) (Karlsson et al., 2003). In humans with nighttime 
eating syndrome (NES) in which frequent waking from sleep during the night is followed 
by food intake, metabolism- and feeding-related rhythms in circulating levels of insulin, 
leptin and ghrelin are phase shifted, and the circadian profile of plasma glucose levels is 
inverted relative to control subjects (Birketvedt et al., 1999; Goel et al., 2009). Studies 
using animal models of environmentally- and genetically-induced circadian rhythm 
disruption have similar implications for clock involvement in metabolic disorders 
including obesity and diabetes. Environmental dysregulation of circadian clock function 
in mice exposed to a 20hr LD cycle produces accelerated weight gain, hyperleptinemia, 
and elevated insulin secretion (Karatsoreos et al., 2011). Furthermore, circadian disruption 
in mice housed in constant light (LL) results in increased body weight gain and fat pad 
mass as well as impaired glucose tolerance (Fonken et al., 2010).  
Consistent with the effects of environmental paradigms, genetic models with mutation 
or deletion of core clock genes correspondingly indicate that global and tissue-specific 
disruption of the circadian clock mechanism is an exacerbating factor in the development 
of metabolic disorders (Turek et al., 2005; Marcheva et al., 2010; Paschos et al., 2012). In 
conjunction with their altered circadian phenotype, Clock mutant mice exhibit many 
hallmarks of metabolic disease, including hyperphagia, obesity, glucose intolerance, and 
insulin resistance (Turek et al., 2005; Marcheva et al., 2010). Furthermore, global and 
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adipocyte-specific circadian disruption caused by deletion of Bmal1 produces a metabolic 
phenotype characterized by increased body weight and adipose tissue mass, adipocyte 
hypertrophy and reduced circulating levels of polyunsaturated fatty acids (Paschos et al., 
2012). Similarly, pancreas-specific Bmal1 mutant mice are distinguished by impaired 
glucose tolerance and reduced insulin secretion (Marcheva et al., 2010). Glucose 
homeostasis is also altered in Cry-deficient (Cry1/Cry2) mice such that glucose tolerance 
is severely impaired but insulin sensitivity remains normal (Lamia et al., 2011; Zhang et 
al., 2010). Conversely, it is interesting that overexpression of Cry1 decreases blood 
glucose levels and improves glucose tolerance in insulin-resistant db/db mice (Zhang et 
al., 2010).  
While these studies provide clear evidence that circadian clock dysregulation plays a 
key role in the development of metabolic diseases such as obesity and diabetes, the specific 
mechanisms underlying the link between circadian clock- and metabolic-dysfunctional 
phenotypes are unknown. Therefore, the central hypothesis of my dissertation research 
is that mutual interactions between circadian clocks and inflammatory signaling are 
critical in the mechanism by which HFD and saturated fats induce proinflammatory 
activation and metabolic dysregulation. To test this hypothesis, my dissertation 
experiments addressed the following specific aims:  
Specific Aim 1: Does high fat diet alter fundamental properties of SCN-driven and 
peripheral circadian rhythms?  (Chapter II);  
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Specific Aim 2: Does environmental desynchronization of circadian rhythms 
recapitulate the effects of clock gene mutations in amplifying proinflammatory status? 
(Chapter III); 
Specific Aim 3: Does inflammatory signaling mediate the differential effects of 
saturated and polyunsaturated fatty acids on circadian clocks? (Chapter IV);  
Specific Aim 4: Do proinflammatory cytokines and other mediators of inflammatory 
signaling govern the effects of high fat diet and saturated fatty acids on peripheral 
circadian clocks? (Chapter V).  
These studies will provide novel information on how mutual interactions between 
circadian clocks, inflammatory signaling pathways and metabolism are important both in 
metabolic homeostasis and the link between clock dysfunction and metabolic phenotypes 
in diet-associated obesity. These studies may ultimately lead to the development of 
chronotherapeutic (i.e., “timed”) drug and/or even diet-specific strategies in the 
treatment/prevention of systemic metabolic disorders and inflammation-related 
pathologies (e.g., cardiovascular disease, stroke, arthritis).  
 
 
  
 23 
 
CHAPTER II  
HIGH FAT DIET MODULATES CIRCADIAN CLOCK PROPERTIES* 
 
Introduction 
Over-nutrition through consumption of high fat diet (HFD) is a major risk factor for 
metabolic disorders that have rapidly increased over the last few decades in association 
with elevated rates of obesity. HFD-induced obesity is highly associated with insulin 
resistance that contributes to the development of a wide variety of metabolic diseases 
including type 2 diabetes, fatty liver disease, and cardiovascular disease (Angulo, 2002; 
Hossain et al., 2007; Jensen et al., 2008). Current evidence indicates that HFD triggers 
chronic low-grade inflammation that is characterized by increased infiltration of immune 
cells, production of pro-inflammatory cytokines and activation of M1 macrophages (pro-
inflammatory) in peripheral tissues such as liver, skeletal muscle and adipose tissue 
(Fujisaka et al., 2009; Lumeng et al., 2007; Weisberg et al., 2003a). Specifically, HFD 
initiates NF-κB mediated production of pro-inflammatory cytokines/chemokines and in 
turn, cytokines/chemokines induce immune cell infiltration and macrophage polarization 
toward M1. As such, HFD-induced inflammation is a key component in the pathogenesis 
of insulin resistance (Guo et al., 2010a; Kang et al., 2008b; Lumeng et al., 2007; Weisberg 
et al., 2003a).  
 
*Reprinted from Xu H, Li H, Woo SL, Kim SM, Shende VR, Neuendorff N, Guo X, Guo 
T, Qi T, Pei Y, Zhao Y, Hu X, Zhao J, Chen L, Chen L, Ji JY, Alaniz RC, Earnest DJ, Wu 
C (2014) Myeloid cell-specific disruption of Period1 and Period2 exacerbates diet-induced 
inflammation and insulin resistance. J Biol Chem 289(23): 16374-88.  
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In addition to its effect on pro-inflammatory responses, HFD also modulates 
fundamental properties of circadian behavioral rhythms and the underlying molecular 
clockworks. For example, long term administration of HFD for 12 weeks increases the 
period of the activity rhythm and alters circadian oscillations in the expression of core 
clock components and clock-controlled genes that mediate nutrient metabolism in 
peripheral tissues in mice (Kohsaka et al., 2007a). In addition, short-term treatment with 
HFD for 1 week induces phase advance of the mPER2::LUC rhythm in the liver 
(Pendergast et al., 2013). However, both long- and short-term HFD treatment have little 
or no effect on SCN-driven behavioral rhythms and clock gene rhythms in the SCN 
relative to its effect on peripheral clocks. Collectively, this evidence indicates that HFD 
can veritably modulate circadian clock properties in peripheral tissues. 
Circadian clocks in peripheral tissues and cells drive daily rhythms and coordinate 
many physiological processes including immune responses and metabolism. For example, 
NF-κB activation in response to immune challenge is rhythmically regulated with 
maximal activation at ZT6 in mice (Spengler et al., 2012), and is mediated by core clock 
components such as CLOCK and CRY (Narasimamurthy et al., 2012). Another key 
component of inflammatory signaling, c-Jun N-terminal kinase (JNK), is also 
phosphorylated rhythmically in rat-1 fibroblasts in vitro (Chansard et al., 2007).  As key 
mediators of inflammation in obesity, macrophages contain cell-autonomous circadian 
clocks that rhythmically modulate LPS-induced secretion of proinflammatory cytokines 
such as TNFα and IL-6 in the spleen (Keller et al., 2009). The abundance of circulating 
immune cells is similarly clock-controlled. For example, leukocyte abundance in the 
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circulation fluctuates on a circadian basis and this rhythm is abolished in Clock mutant 
mice (Oishi et al., 2003; Oishi et al., 2006). 
Recent observations suggest that circadian clocks play a key role in the regulation of 
metabolic homeostasis and that the disruption or even dysregulation of circadian 
timekeeping triggers the development of metabolic disease including obesity and diabetes. 
In mice with genetic mutation or deletion of core clock genes, global or adipocyte-specific 
disruption of circadian clock function has been shown to produce obesity or significant 
alterations in metabolism as well as exacerbated pro-inflammatory responses (Castanon-
Cervantes et al., 2010; Marcheva et al., 2010; Paschos et al., 2012; Turek et al., 2005). 
However, the specific mechanism underlying the link between circadian clock- and 
metabolic-dysregulated phenotypes is unknown. As key components of inflammation in 
HFD induced obesity, macrophages contain cell-autonomous circadian clocks that have 
been shown to gate macrophage inflammatory responses including rhythms in LPS-
induced cytokine secretion (Gibbs et al., 2012; Keller et al., 2009).  Because HFD induces 
adipose tissue circadian clock dysregulation in conjunction with adipose tissue 
macrophage pro-inflammatory activation (Kohsaka et al., 2007a) environment-mediated 
circadian disruption amplifies macrophage pro-inflammatory responses (Castanon-
Cervantes et al., 2010), our hypothesis is that over-nutrition causes circadian dysregulation 
in macrophage clocks, which in turn exacerbates pro-inflammatory activation and fat 
deposition in adipose tissue, thus leading to systemic insulin resistance. We initially tested 
this hypothesis by determining whether HFD induces circadian clock dysregulation in 
indigenous and adipose tissue macrophages.  
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Material and Methods 
Animals: Animals (male and female, 6 weeks old) used in this study were derived 
from breeding pairs of homozygous mPer2Luc knock-in mice (C57BL/6J background; 
generously provided by Dr. Joseph Takahashi, UT Southwestern Medical School, Dallas, 
TX). In homozygous mPer2Luc mice, a luciferase (Luc) gene was fused in-frame to the C-
terminus of the endogenous mPER2 coding sequence so as to enable continuous recording 
of Per2 oscillations via luciferase bioluminescence (Yoo et al., 2004a). All mice were 
maintained on a 12:12-h light-dark cycle (lights on at 06:00). All study protocols were 
reviewed and approved by the Institutional Animal Care and Use Committee of Texas 
A&M University. 
 
Wheel running activity: To examine the dietary effect on in vivo circadian clock 
rhythmic in relation to obesity-associated metabolic phenotypes, mPer2Luc mice were 
subjected to HFD (60% fat calories, 20% protein calories, and 20% carbohydrate calories, 
Table 1) feeding. Briefly, female homozygous mPer2Luc mice, at 5 – 6 weeks of age, were 
fed an HFD for 12 weeks as previously described (Guo et al., 2010b; Huo et al., 2010a). 
Age- and gender-matched mPer2Luc mice were fed a low-fat diet (LFD, 10% fat calories, 
20% protein calories, and 70% carbohydrate calories) and used as controls. After the 
feeding regimen, both HFD-fed and LFD-fed mPer2Luc mice were subjected to 
examination of wheel-running locomotor activity rhythms in constant darkness as 
previously described (Ko et al., 2011).   
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 Table 1. Formula of high fat diet (from Research diets. Inc) 
 
 
  
HFD        gm%       kcal% 
Protein   26.2 20 
Carbohydrate   26.3 20 
Fat   34.9 60 
  Total  100 
  kcal/gm 5.24  
     
Ingredient     gm kcal 
Casein, 30 Mesh  200 800 
L-Cystine   3 12 
Corn Starch   0 0 
Maltodextrin 10   125 500 
Sucrose   68.8 275.2 
Cellulose, BW200  50 0 
Soybean Oil   25 225 
Lard   245 2205 
Mineral Mix S10026  10 0 
DiCalcium Phosphate  13 0 
Calcium Carbonate  5.5 0 
Potassium Citrate, 1 H2O  16.5 0 
Vitamin Mix V10001  10 40 
Choline Bitartrate  2 0 
FD&C Blue Dye#1  0.05 0 
Total     773.85 4057 
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Isolation of stromal vascular cells from adipose tissue: Adipose tissue stromal 
vascular cells (SVC) were isolated using the collagenase digestion method as previously 
described (Huo et al., 2010a; Stienstra et al., 2008). After digestion and centrifugation, the 
pelleted cells were collected as SVC. Adipose tissue SVC from mPer2Luc mice were 
subjected to bioluminescence analysis as previously described (Farnell et al., 2011).    
 
Macrophage differentiation and characterization: Bone marrow cells were isolated 
from the tibias and femurs of LFD- and/or HFD-fed mPer2Luc mice as previously 
described (Odegaard et al., 2007a). After differentiation with Iscove's modified 
Dulbecco’s medium (IMDM) containing 10% fetal bovine serum and 15% L929 culture 
supernatant for 8 days, bone marrow-derived macrophages (BMDM) were subjected to 
analysis of circadian rhythms of bioluminescence.  
 
Circadian properties of mPer2Luc SVC and BMDM cells: SVC and BMDM prepared 
from LFD- and/or HFD-fed mPer2Luc mice were suspended in supplemented Dulbecco’s 
modified Eagle’s medium (DMEM) (for SVC) or IMDM (for BMDM) and then plated on 
35mm culture dishes (Corning). For both cell types, the medium was changed 
approximately 24 hr after plating so as to reduce the FBS concentration to 5% and about 
12 hr later cultures were exposed to medium containing 50% adult horse serum for 2 hr. 
Thereafter, serum-shocked SVC and BMDM were maintained in serum-free recording 
medium containing 0.1mM beetle luciferin (Promega), 25 units/ml penicillin, and 25 
ug/ml streptomycin for bioluminescence analysis as described previously (Ko et al., 2011). 
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Individual cultures were sealed airtight with sterile glass coverslips (VWR), and sterile 
silicon grease (Dow Corning). The temporal patterns of mPER2::LUC bioluminescence 
were analyzed using an automated 32-channel luminometer (LumiCycle; Actimetrics, 
Wilmette, IL, USA) that was maintained within a standard cell culture incubator at 35°C. 
Bioluminescence from individual cultures was continuously recorded with a 
photomultiplier tube (PMT) for ~70 sec at intervals of 10 minutes. Due to the transient 
induction of bioluminescence following the medium change at the initiation of this 
analysis, the first cycle was excluded from data analysis. Bioluminescence data was 
analyzed using the Lumicycle Analysis program (Actimetrics). For each raw data set, 
baseline drift was removed by fitting a polynomial curve with an order equal to one less 
than the number of recorded cycles. Rhythm parameters were determined from baseline-
subtracted data using LM (damped Sine) Fit.  
 
Statistical methods: Numeric data are presented as means ± SE (standard error). 
Statistical significance was assessed by unpaired, two-tailed Student’s t tests. Differences 
were considered significant at the two-tailed P < 0.05. 
 
Results 
HFD induces a small, but significant, increase in the period of the circadian rhythm 
of mouse wheel running activity: To address a possible link between metabolic phenotype 
and alterations in circadian clock function, dietary effects on circadian rhythms in vivo 
were examined in homozygous mPer2Luc knock-in mice (C57BL/6J background) that were 
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fed either a HFD or LFD for 12 weeks in constant darkness. During the 12-week treatment 
interval, both LFD- and HFD-fed mice exhibited clear free-running activity rhythms in 
DD.  Although the general rhythmic patterns absolute levels of wheel-running activity in 
DD were comparable in both treatment groups, the free-running period of the activity 
rhythm in HFD-fed mPer2Luc mice was significantly increased (p<0.001) by ≈0.4hr 
relative to that observed in LFD-fed mice (Figure 1; mean  = 24.2 ± 0.1 vs 23.8 ± 0.1 hr, 
respectively). 
 
HFD feeding lengthens the period of clock gene oscillations in mouse adipose tissue 
stromal vascular cells and bone marrow-derived macrophages: Given the role of 
macrophages in inflammation (Huo et al., 2010a; Lumeng et al., 2007), we analyzed 
circadian oscillations of the clock gene Per2 in adipose tissue SVC, the immune cell-
containing fraction of collagenase-digested visceral fat that has been widely used to 
examine the inflammatory status of adipose tissue macrophages (Lumeng et al., 2007; 
Odegaard et al., 2007a), and BMDM derived from mPer2Luc mice. SVC cultures from 
LFD-fed mice exhibited robust mPER2::LUC rhythms with a circadian period of 25.06  
0.4 hrs (Figure 2A). However, SVC cultures from HFD-fed mice were characterized by 
mPER2::LUC rhythms in which the period was significantly increased (p<0.05) by ~ 9 
hrs (Figure 2A). Similarly, the period of BMDM rhythms in mPER2::LUC 
bioluminescence was significantly increased (p<0.05) in cultures from HFD-fed mPer2Luc 
mice relative to those from LFD-fed mice (Figure 2B). BMDM cultures from HFD-fed  
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Figure 1: HFD alters the free-running period of the mouse activity rhythm. (A) 
Representative circadian rhythms of wheel-running activity in mice (5 – 6 weeks of age) 
that were fed a low-fat diet (LFD) (left panel) or high-fat diet (HFD) for 12 weeks (n = 5 
– 10) and exposed to constant darkness. (B) Bar graph depicts differences in the free-
running period of the activity rhythm between treatment groups. Data are means ± SEM 
in bar graph. ***, p < 0.001, HFD vs. LFD. 
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Figure 2: HFD lengthens the period of clock gene oscillations in adipose tissue SVC and 
in macrophages. Representative temporal patterns of ensemble PER2::LUC 
bioluminescence (expressed as detrended baseline-subtracted counts per second) in 
cultures of (A) adipose tissue stromal vascular cells (SVC) or (B) bone marrow-derived 
macrophages (BMDM) derived from mPer2Luc mice (5 – 6 weeks of age) that were fed a 
LFD or HFD for 12 weeks (n = 5 – 6). Bar graphs depict group differences in PER2::LUC 
rhythm period between treatment groups. For bar graphs (A and B), data are means ± 
SEM. *, P < 0.05 and **, P < 0.01 HFD vs. LFD (A and B). 
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mPer2Luc mice were also distinguished by robust decreases in the amplitude of the 
mPER2::LUC rhythm. 
 
Discussion 
During obesity, macrophage pro-inflammatory activation initiates or aggravates 
inflammation in key metabolic organs including adipose and liver tissues, thereby leading 
to systemic insulin resistance. However, it remains to be elucidated exactly how over-
nutrition induces pro-inflammatory activation of macrophages, particularly in those found 
in adipose tissue where increased inflammation plays a causal role in the pathogenesis of 
insulin resistance (Guo et al., 2010b; Huo et al., 2010a; Kang et al., 2008a; Lumeng et al., 
2007; Weisberg et al., 2003b). In parallel with this inductive effect on macrophage pro-
inflammatory activation (Lumeng et al., 2007), HFD feeding has been shown to decrease 
the amplitude of adipose tissue clock gene rhythms in Bmal1, Clock, and Per 2 expression 
(Kohsaka et al., 2007b) and to lengthen the period of the Per2 rhythm in cultured adipose 
tissue (Shi et al., 2013a). Taken together, these observations suggest that dysregulation of 
peripheral circadian clocks may link diet-associated obesity to adipose tissue 
inflammation. In support of this putative association, the present study demonstrates that 
in HFD-fed mice where minor increases in period of the activity of rhythm were similar 
to those observed previously (Kohsaka et al., 2007b), over-nutrition caused dysregulation 
of peripheral circadian clocks (i.e., substantial increases in the period of Per 2 oscillations) 
specifically within  key mediators of adipose tissue inflammation, macrophages in stromal 
vascular cells and BMDM.  
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Importantly, the results of the current study are consistent with previous observations 
indicating that HFD-induced alterations in the circadian timekeeping properties of 
peripheral clocks are considerably greater in comparison with its impact on SCN clock 
gene oscillations and SCN-driven rhythms. In this regard, Kohsaka and colleagues 
(Kohsaka et al., 2007a) have reported that HFD treatment for 6 weeks similarly has little 
or no effects on the free-running period of the mouse activity rhythm and hypothalamic 
(near SCN) clock gene oscillations but induces severe damping of the same rhythms in 
liver and fat. Similarly, short-term HFD treatment (7days) advanced the phase of clock 
gene rhythms in mouse liver by about 5hr, but the phase of SCN clock gene oscillations 
was not affected (Pendergast et al., 2013). At present, the basis for the differential effects 
of HFD on SCN and peripheral clocks is unclear. Because HFD activates inflammatory 
signaling pathways and increases immune cell infiltration into tissue (Lumeng et al., 2007; 
Westfall et al., 2013; Yoshida et al., 2013), differences in the trafficking of immune cells 
and other mediators of inflammation may govern the extent to which HFD affects 
peripheral versus central clocks. The central nervous system (CNS) is distinguished by 
immune privilege so as to protect neuronal cells from damage caused by inflammation 
(Wenkel et al., 2000).  The blood-brain barrier shields the CNS against this type of insult 
by restricting the migration and infiltration of peripheral immune cells into the brain 
(Engelhardt, 2008). Consequently, the brain is protected under normal circumstances from 
HFD-induced activation of peripheral macrophages and proinflammatory signaling and 
this may account for the predominant impact of HFD on peripheral clocks.    
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Because adipose tissue inflammatory responses and corresponding insulin sensitivity 
in over-nutrition-related obesity are differentially engaged by specific types of fatty acids 
found in HFDs, future studies are warranted to compare the effects of saturated and 
polyunsaturated fatty acids on macrophage and adipocyte circadian clocks. Thus, it will 
be important to determine whether saturated fatty acids that activate pro-inflammatory 
signaling pathways and lead to impaired insulin sensitivity (e.g., palmitate) also modulate 
the circadian timekeeping function of macrophage and adipocyte clocks and whether this 
circadian clock dysregulation is blocked or abated by polyunsaturated fatty acids that 
repress adipose tissue inflammatory responses and have a beneficial impact on insulin 
sensitivity. 
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CHAPTER III  
ENVIRONMENTAL DESYNCHRONIZATION OF CIRCADIAN RHYTHMS 
AMPLIFIES DIET-INDUCED INFLAMMATION IN CONCERT WITH SYSTEMIC 
METABOLIC DYSREGULATION 
 
Introduction  
Circadian clocks located in peripheral tissues and cells throughout the body regulate 
daily rhythms that provide for the temporal organization of many local physiological 
processes including inflammation and metabolism. Functional properties of immune cells 
are rhythmically regulated by circadian clock machinery. For example, monocytes and 
macrophages exhibit rhythms in cytokine release during exposure to light-dark cycles and 
constant environmental conditions (Born et al., 1997; Rahman et al., 2015). In addition, 
TLR9 expression in macrophages is clock-controlled, thus mediating rhythmic responses 
to immunization in mice (Silver et al., 2012b). In mammals, robust circadian rhythms are 
also observed in metabolic processes such as lipid levels in the circulation which peak 
rhythmically in the morning (Dallmann et al., 2012).    Thus, this precise temporal 
coordination of inflammatory responses and metabolism is thought to be critical for the 
maintenance of physiological homeostasis. 
As indicated previously, dysregulation or disruption of circadian timekeeping 
contributes to the development of metabolic disorders including obesity and diabetes. In 
this regard, most studies have used mice with genetic mutation or deletion of core clock 
genes to demonstrate that global, or adipocyte-specific, disruption of circadian clock 
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function produces obesity or other signs of metabolic dysregulation (Paschos et al., 2012; 
Shi et al., 2013b).  Similarly, our published studies using mice with targeted disruption of 
the Per1 and Per2 genes demonstrate that clock disruption exacerbates high fat diet-
induced inflammation, resulting in systemic insulin resistance. This observation suggests 
that clock malfunction may play a key role in the mechanism by which diet-induced 
obesity triggers macrophage proinflammatory activation, adipose tissue inflammation, 
and insulin resistance. 
Because many of the clock genes targeted in our and other studies function as 
transcription factors that regulate important mediators of inflammatory responses (e.g., 
Toll-like receptor [TLR], CCL2, IL-6, PPAR) (Curtis et al., 2014; Lam et al., 2013; 
Nguyen et al., 2013; Silver et al., 2012a), it is possible that the altered inflammatory and 
metabolic phenotypes observed using genetic models are due to the disruption of non-
clock, rather than circadian timekeeping, functions of core clock genes. To address this 
possibility and the implications of non-clock functions of core clock genes in interpreting 
results obtained with genetic models, many studies have resorted to environmental 
disruption of circadian rhythms using chronic jet lag or shift work paradigms. Interestingly, 
animals used in these studies display similar metabolic phenotypes as those found in 
genetic models. For example, mice exposed to chronic jet lag paradigms gain more body 
weight and show higher lipid levels in the circulation and increased adiposity relative to 
controls (Casiraghi et al., 2016). Therefore, the objective of this study was to determine 
whether environmental desynchronization of circadian rhythms in response to chronic 
shifts in the light-dark cycle (12hr every 5 days) recapitulates the effects of clock gene 
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deletions or mutations on HFD-induced macrophage polarization and infiltration, 
proinflammatory signaling, as well as glucose and insulin tolerance.  
 
Material and Methods 
Animals: Animals (male and female, 6 weeks old) used in this study were derived 
from breeding pairs of homozygous mPer2Luc knock-in mice (C57BL/6J background) or 
WT mice (129J background) obtained from the Jackson Laboratory (Bar Harbor, Maine, 
USA). Homozygous mPer2Luc mice are characterized by a luciferase (Luc) gene fused in-
frame to the C-terminus of the endogenous mPER2 coding sequence so as to enable real-
time recording of circadian oscillations in mPER2-driven bioluminescence (Yoo et al., 
2004a). All animal procedures used in this study were conducted in compliance with 
Animal Use Protocol #2014-0248 as reviewed and approved by the Institutional Animal 
Care and Use Committee of Texas A&M University. 
 
Wheel running activity: To examine the effect of environmental disruption of 
circadian rhythms in vivo circadian clock rhythmicity, mPer2Luc mice were maintained on 
a 12:12-h light-dark cycle (lights on at 07:00) for about 2 weeks, and then randomly 
divided into 2 groups exposed either to this “fixed” (control) LD 12:12 cycle or to a 
“shifted” LD cycle. In shifted LD cycle, lights on was advanced by 12 hours every 5 days 
for about 10 weeks. In all fixed- or shifted-LD mice, wheel-running activity was 
continuously recorded, stored in 10-minute bins, graphically depicted in actograms and 
analyzed using ClockLab data collection and analysis software (ActiMetrics) as 
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previously described (Ko et al., 2011). Entrainment and qualitative parameters of the 
activity rhythm were measured over the same interval for all animals. Chi-square 
periodogram analysis was used to determine the period of the activity rhythm during 
exposure to the fixed or shifted LD cycles.    
 
Glucose and Insulin tolerance tests: To examine the effect of environmental 
disruption of circadian rhythms on obesity-associated metabolic phenotypes in vivo, 5-6 
week old mPer2Luc mice exposed to fixed or shifted LD cycles were fed a high-fat diet 
(60% fat calories, 20% protein calories, and 20% carbohydrate calories) for approximately 
8 weeks as described previously (Guo et al., 2010b; Huo et al., 2010a). Body weight was 
recorded every 10 days during the HFD feeding regimen. All metabolic testing was 
conducted so as to occur at similar times during the circadian cycle in both fixed- or 
shifted-LD mice. For glucose tolerance and insulin resistance testing, mice were fasted for 
12 h and 6 h respectively. Glucose tolerance tests were initiated at ZT 2 (9am) by 
intraperitoneal injection of D-glucose (2g/kg body weight) and collecting blood samples 
from the tail vein immediately before and at 15, 30, 60, and 120 min afterward. Insulin 
resistance tests were initiated at ZT 7 (2pm) intraperitoneal injection of insulin (1 unit/kg 
body weight)  and collecting blood samples from the tail vein immediately before and at 
30, 60, and 120 min afterward.  
 
Isolation of stromal vascular cells from adipose tissue: Epididymal adipose tissue  
was collected from HFD-fed mPer2Luc mice exposed to fixed or shifted LD cycles and 
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stromal vascular cells (SVC) were isolated using the collagenase digestion method as 
previously described (Huo et al., 2010a; Stienstra et al., 2008). After digestion and 
centrifugation, the pelleted adipose tissue SVC cells were cultured for 7 days, and then 
independently subjected to FACS analysis, real-time PCR analysis of inflammatory 
cytokines and bioluminescence analysis of clock gene rhythms as previously described 
(Farnell et al., 2011; Xu et al., 2014).  
 
Macrophage differentiation and characterization: Bone marrow cells were isolated 
from the tibias and femurs of HFD-fed mPer2Luc mice exposed to fixed or shifted LD 
cycles as previously described (Odegaard et al., 2007a). After differentiation with 
Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal bovine serum and 
10ng/ml monocyte-colony stimulating factor (M-CSF) for 7 days, bone marrow-derived 
macrophages (BMDM) were independently subjected to bioluminescence analysis of 
clock gene rhythms, FACS analysis and real-time PCR analysis of inflammatory 
cytokines.  
 
Circadian properties of mPer2Luc SVC and BMDM cells: SVC and BMDM prepared 
from HFD-fed mPer2Luc mice exposed to fixed or shifted LD cycles were cultured in 
supplemented Dulbecco’s modified Eagle’s medium (DMEM) and then maintained in 
serum-free recording medium containing 1uM forskolin, 25mM HEPES, 292µg/ml L-
glutamine, 100units/ml penicillin, 100μg/ml streptomycin and 10uM luciferin (Promega) 
for bioluminescence analysis as described previously (Ko et al., 2011). Individual cultures 
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were sealed airtight with sterile glass coverslips (VWR), and sterile silicon grease (Dow 
Corning). The temporal patterns of mPER2::LUC bioluminescence were analyzed using 
an automated 32-channel luminometer (LumiCycle; Actimetrics, Wilmette, IL, USA) that 
was maintained within a standard cell culture incubator at 32°C. Bioluminescence from 
individual cultures was continuously recorded with a photomultiplier tube (PMT) for ~70 
sec at intervals of 10 minutes. Due to the transient induction of bioluminescence following 
the medium change at the initiation of this analysis, the first cycle was excluded from data 
analysis. Bioluminescence data was analyzed using the Lumicycle Analysis program 
(Actimetrics). For each raw data set, baseline drift was removed by fitting a polynomial 
curve with an order equal to one less than the number of recorded cycles. Rhythm 
parameters were determined from baseline-subtracted data using Levenberg-Marquardt 
(damped Sine) Fit.  
 
Flow cytometry analysis: SVC and BMDM derived from HFD-fed mPer2Luc exposed 
to fixed or shifted LD cycles were stained with fluorescence-tagged antibodies: anti-F4/80, 
anti-CD11b for macrophages, and anti-CD11c and anti-CD206 for macrophage activation 
as previously described (Prieur et al., 2011), and subjected to FACS analyses using Accuri 
flow cytometer (BD Biosciences, San Jose, California, USA). Briefly, the harvested cells 
were analyzed based on FSC-A and SSC-A. Live cells were then examined for F4/80 
(FITC) and CD11b (PerCP/Cy5.5) expression. Mature macrophages (F4/80+ CD11b+ 
cells) were then gated for CD11c (PE/Cy7) and CD206 (PE) expression (macrophage 
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polarization). Mature macrophages that were positive for CD11c but negative for CD206 
were considered as M1 macrophages (F4/80+ CD11b+ CD11c+ CD206– cells). 
 
RNA isolation, reverse transcription, and real-time PCR: To examine macrophage 
pro-inflammatory activation and signaling, SVC and BMDM were treated with PBS or 
LPS (10 ng/ml) for 30 min prior to cell harvest. Total cellular RNA Total cellular RNA 
was later extracted from individual cultures of SVC and BMDM cells using PureLink 
RNA mini kit (Ambion, Waltham, MA) according to the manufacturer’s protocols. 
Relative quantification of interleukin-6 (IL-6) and tumor necrosis factor α (TNFα) mRNA 
abundance was performed using SYBR-Green PCR technology [Applied Biosystems Inc. 
(ABI)] as described previously (Farnell et al., 2011; Xu et al., 2014). For each sample, 
real-time PCR analysis of IL-6 or TNFα  mRNA levels was performed on duplicate 
aliquots using the cDNA equivalent of 1ng of total RNA. To control for differences in 
sample RNA content, β-actin mRNA was amplified with the cDNA equivalent of 1ng 
total RNA from the same samples. The comparative CT method was utilized to calculate 
the relative abundance for a given cytokine mRNA by normalization to corresponding β-
actin levels in each sample and to a calibrator consisting of pooled cDNA from multiple 
samples. Results were normalized to -actin mRNA and adjusted relative to the averages 
of fixed LD controls, which were arbitrarily set as 100%.   
 
Statistical methods: Statistical significance was assessed by pooled Student’s t tests. 
Differences between fixed and shifted LD groups were considered significant at p< 0.05. 
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Results 
Shifted LD cycles disrupt circadian entrainment of the rhythm in mouse wheel-
running activity: To determine whether environmental manipulations simulating shift 
work-type schedules induce circadian rhythm disturbances or desynchronization, wheel 
running activity was examined in mice exposed to either fixed or shifted LD cycles for 
about 10 weeks. Throughout the 10 weeks of analysis, all mice maintained on a fixed LD 
cycle showed stable entrainment (Figure 3) such that their daily onsets of activity 
consistently occurred shortly after lights off (at 1900hr). However, mice exposed to shifted 
LD cycles were distinguished by desynchronized patterns of wheel-running behavior in 
which the timing of activity onsets relative to lights-off was highly variable from day to 
day. Consistent with their desynchronized activity patterns, the mean period of the activity 
rhythm in shifted LD mice was considerably greater than 24hr ( = 25.5 ± 0.5 hr). 
 
Effect of shifted LD cycles on clock gene rhythms in lymphoid tissues and cells: 
Lymphoid tissues and cells play an important role in inflammation and metabolism. In 
order to understand whether chronic shifts of the LD cycle alter clock gene rhythms in 
lymphoid tissues/cells, circadian oscillations of the peripheral clock gene Per2 were 
analyzed in spleen, adipose tissue SVC and BMDM isolated from mPer2Luc mice.  The 
spleen, which plays a role in inflammation as well as lipid metabolism in response to HFD 
(Fatouros et al., 1995), of HFD-fed mice maintained on fixed LD cycles displayed robust 
mPER2::LUC rhythms with a circadian period of 23.18  0.3 hrs. However, exposure to 
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Figure 3: Shifted LD cycles disrupt circadian entrainment of the rhythm in mouse wheel-
running activity. Representative records of wheel-running activity in mice (5 – 6 weeks of 
age) that were maintained in a fixed LD 12:12 cycle (left) or exposed to a shifted (12h 
advance every 5 days) LD 12:12 cycle (right). The open and closed bars at the top 
respectively signify the timing of the light and dark phase in the fixed and shifted LD 
12:12 cycles. 
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shifted LD cycles significantly decreased (p<0.05) by about 1hr the period of 
mPER2::LUC rhythms in spleen cultures from HFD-fed mice (Figure 4A). Similarly, the 
period of PER2::LUC rhythms in SVC cultures isolated from HFD-fed mice on shifted 
LD cycles was significantly decreased (p<0.05) relative to the SVC rhythms observed in 
HFD-fed mice on fixed LD cycles (22.49   0.4 hrs in the fixed LD cycles vs. 21.47  0.2 
hrs in the shifted LD cycles) (Figure 4B).  In BMDM cultures from HFD-fed mice, there 
was no significant difference in the period of the PER2::LUC rhythms in the fixed and 
shifted LD groups (Figure 4C).   
 
Circadian desynchronization by shifted LD cycles increases macrophage pro-
inflammatory activation: Since the circadian clock is deeply involved in regulating 
immune system and macrophages play a critical role in inflammation (Huo et al., 2010a; 
Lumeng et al., 2007), we examined macrophage pro-inflammatory activation and immune 
response in SVC, the immune cell-containing fraction of adipose tissue, and BMDM 
derived from HFD-fed mPer2Luc mice kept either in fixed or shifted LD cycles. Similar to 
our observations based on the genetic disruption of myeloid cell-specific circadian clock 
function (Xu et al., 2014), circadian rhythm desynchronization during exposure to shifted 
LD cycles increased adipose tissue infiltration of pro-inflammatory macrophages. 
Following HFD treatment, the SVC of mice exposed to shifted LD cycles were 
distinguished by a significant (p<0.05) increase in mature macrophages (F4/80+ CD11b+ 
cells) relative to those found in fixed LD controls (Figure 5). Further analysis of the 
inflammatory status of the mature macrophages revealed that adipose tissue SVC from   
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Figure 4: Effect of shifted LD cycles on the period of clock gene oscillations in lymphoid 
tissues and cells. Representative temporal patterns of ensemble PER2::LUC 
bioluminescence (expressed as detrended baseline-subtracted counts per second) in 
cultures of (A) spleen, (B) adipose tissue stromal vascular cells (SVC) or (C) bone 
marrow-derived macrophages (BMDM) from HFD-fed mPer2Luc mice that were 
maintained in a fixed LD 12:12 cycle (black) or exposed to a shifted (12h advance every 
5 days) LD 12:12 cycle (red). Bar graphs depict comparisons of the circadian period (mean 
+ SEM) of the PER2::LUC rhythms in cultures from the fixed and shifted LD groups. 
Asterisk indicates that the period of the PER2::LUC rhythms in cultures from fixed LD 
controls was significantly greater (p<0.05) than that in tissue or cells from shifted LD 
mice. 
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Figure 5: Environmental desynchronization of circadian rhythms exacerbates diet-
induced adipose tissue inflammation. FACS analyses of mature macrophages (CD11b+ 
and F4/80+ cells, upper right corner on the scatter plot) in adipose tissue SVC from HFD-
fed mice that were maintained in a fixed LD 12:12 cycle (left scatter plot) or exposed to 
a shifted (12h advance every 5 days) LD 12:12 cycle (right scatter plot). Bar graphs depict 
quantification of the percentages (mean ± SEM) of macrophage infiltration, 
proinflammatory M1 macrophages (F4/80+ CD11b+ CD11c+ CD206− cells) and anti-
inflammatory M2 macrophages (F4/80+ CD11b+ CD11c− CD206+ cells) in SVC 
isolated from HFD-fed mice in the fixed and shifted LD groups. *, #, p < 0.05, Fixed vs. 
Shifted.  
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shifted LD showed a significant increase in pro-inflammatory M1 macrophages (F4/80+ 
CD11b+ CD11c+ CD206− cells) and decrease in anti-inflammatory M2 macrophages 
(F4/80+ CD11b+ CD11c− CD206+ cells) compared to the observed percentages in fixed 
LD controls (Figure 5). Furthermore, BMDM from mice exposed to shifted LD cycles 
similarly showed a significantly (p<0.05) higher percentage of M1 macrophages relative 
to that observed in fixed LD BMDM (Figure 6).  
Consistent with the increases in M1 macrophages associated with circadian rhythm 
desynchronization, LPS-induced increases in BMDM expression of pro-inflammatory 
cytokines were much greater in shifted LD mice than in fixed LD controls. In response to 
LPS treatment, IL-6, IL-1 and TNF mRNA levels in BMDM from HFD-fed mice on 
shifted LD cycles were significantly increased (p<0.05) relative to their respective levels 
in BMDM from HFD-fixed LD-exposed mice (Figure 7). 
 
Circadian desynchronization by shifted LD cycles exacerbates HFD-induced insulin 
resistance and glucose intolerance: High fat diet increases macrophage pro-inflammatory 
activation (Xu et al., 2014) and the corresponding induction of inflammatory signaling 
contributes to the development of insulin resistance and glucose intolerance (Han et al., 
2013; Solinas et al., 2007), which are major phenotypes of metabolic disorders. Therefore, 
we next determined whether the changes in inflammatory status observed in shifted LD 
mice were accompanied by corresponding indices of metabolic dysregulation. During 
HFD feeding for 8 weeks, LD shifted mice exhibited a progressive increase in body weight  
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Figure 6: Environmental desynchronization of circadian rhythms increases diet-induced 
macrophage proinflammatory activation.  FACS analyses of proinflammatory M1 
macrophage (F4/80+ CD11b+ CD11c+ CD206− cells, upper left corner on the scatter plot) 
and anti-inflammatory M2 macrophages (F4/80+ CD11b+ CD11c− CD206+ cells, lower 
right corner on the scatter plot) in BMDM of HFD-fed mice that were maintained in a 
fixed LD 12:12 cycle (left scatter plot) or exposed to a shifted (12h advance every 5 days) 
LD 12:12 cycle (right scatter plot). Bar graphs depict quantification of proinflammatory 
M1 macrophages and anti-inflammatory M2 macrophages in cultured BMDM obtained 
from mice in the fixed and shifted LD groups. The depicted data are means ± SEM. *, p < 
0.05, Fixed vs. Shifted.  
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Figure 7: Environmental desynchronization of circadian rhythms increases expression of 
proinflammatory cytokines in response to LPS stimulation in BMDM. BMDM cultures 
were treated with LPS (10 ng/ml) or PBS for 30 mins before cell harvest. The mRNA 
levels of IL-1β, IL-6, and TNFα were quantified using real-time PCR and plotted as fold 
induction relative to PBS control group. For bar graphs, data are the means ± SEM. *, p < 
0.05, Fixed vs. Shifted  
Fixed 
LPS 
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LPS 
* *
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LPS 
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compared to those maintained on a fixed LD cycle. Before HFD feeding, the body weight 
of shifted LD mice did not differ from that observed in LD controls. However, the HFD-
induced increase in body weight of shifted LD mice was significantly (p < 0.05) greater 
than that found in fixed LD controls. Importantly, the observed effect of shifted LD on the 
body weight was not associated with a corresponding change in food intake because total 
daily consumption of HFD was similar in the fixed and shifted LD groups (Figure 8A). 
However, it is interesting that food consumption in LD shifted mice was almost equally 
distributed between the day and night whereas fixed LD mice consumed significantly 
(p<0.05) more food during night than day (Figure 8A). As a result of these treatment 
differences in the diurnal distribution of food intake, daytime HFD consumption was 
significantly (p<0.05) greater in shifted LD mice than fixed LD controls. Consistent with 
our reported findings on the metabolic dysregulation induced by myeloid cell-specific 
Per1/2 disruption (Xu et al., 2014), HFD-fed mice on shifted LD cycles displayed 
increases in the severity of systemic glucose intolerance and insulin resistance, such that 
plasma glucose levels at 30, 60 and 120min after initiation of these metabolic tests were 
significantly (p<0.05) higher in shifted LD mice than fixed LD controls (Figure 8B). Thus, 
environmental desynchronization of circadian rhythms is sufficient to recapitulate the 
effects of genetic disruption of circadian clock function in amplifying HFD-induced 
inflammation in concert with systemic metabolic dysregulation. 
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Figure 8: Environmental desynchronization of circadian rhythms exacerbates diet-
induced insulin resistance and glucose intolerance. Graphs depict determinations (means 
± SEM) of: (A) body weight (every 10 days), average daily food intake, and day-night 
distribution of HFD consumption; and (B) plasma glucose levels at timed intervals 
following intraperitoneal injection of (left panel) glucose (2 g/kg; glucose tolerance test) 
or (right panel) insulin (1 U/kg; insulin tolerance test) in mice that were fed an HFD for 8 
weeks and exposed to fixed or shifted LD cycles (n = 12), For A – B, *, p<0.05 fixed vs. 
shifted LD groups. 
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Discussion 
The link between circadian rhythm disruption and metabolic phenotypes is well 
established by studies using transgenic mice with genetic mutation or deletion of core 
clock genes. For example, hyperlipidemia, hyperglycemia, and hypoinsulinemia were 
observed in Clock∆19/∆19 and Bmal1-/- mice. In addition, pancreas specific clock mutant 
mice also displayed glucose intolerance and low level of insulin secretion associated with 
impaired β-cell function (Marcheva et al., 2010; Turek et al., 2005). Similar to the effects 
of global arrhythmicity observed in Clock mutant and Bmal1-deficient mice, our previous 
studies demonstrate that transplantation of Per1/2-disrupted bone marrow cells into 
irradiated wild-type mice amplifies the severity of HFD-induced metabolic dysregulation 
(Xu et al., 2014). However, it is unclear whether the metabolic-dysregulated phenotypes 
are caused by the disruption of the circadian timekeeping function or transcriptional 
regulatory activity of these core clock genes. In the present experiments, chronic 12-hour 
advances in the LD cycle were observed to disrupt photic entrainment of circadian 
behavior, modulate clock gene rhythms in adipose tissue macrophages and similarly 
exacerbate HFD-induced increases in body weight, glucose intolerance and insulin 
resistance. Importantly, these findings are consistent with other rodent studies examining 
the effects of various chronic jet lag or shift work paradigms on diet-induced metabolic 
pathophysiology (Iwamoto et al., 2014; Oike et al., 2015), indicating that environmental 
desynchronization of circadian rhythms is sufficient to disrupt metabolic homeostasis. 
Interestingly, increased daytime HFD consumption, but not total daily food intake, in 
shifted LD mice may contribute to the observed increases in body weight, glucose 
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intolerance and insulin resistance because the coincidence of HFD feeding during the 
daytime or inactive phase in rodents has been identified as a determining factor in diet-
mediated metabolic dysfunction (Arble et al., 2009; Hatori et al., 2012).   Collectively, 
these observations have important implications in the interpretation of previous studies 
using genetic models, suggesting that the systemic metabolic dysregulation is a 
consequence of the disruption of the circadian timekeeping function of core clock genes, 
not their role as transcription factors that regulate downstream signaling pathways.  
Chronic inflammation is thought to play an important role in diet-associated obesity 
and metabolic syndrome. In particular, studies on human obesity suggest that chronic 
activation of proinflammatory signaling pathways induces low grade inflammation, which 
in turn leads to decreased insulin sensitivity (Hotamisligil et al., 1995; Sartipy and 
Loskutoff, 2003). As such, inflammation may provide a critical link between circadian 
clock- and metabolic-dysregulated phenotypes. Circadian disruption using a chronic jet 
lag paradigm is characterized by increased inflammation and proinflammatory responses 
of the innate immune system (Castanon-Cervantes et al., 2010; Xu et al., 2014). 
Furthermore, we have shown that  macrophages from mice with targeted disruption of 
Per1 and Per2 are distinguished by enhanced proinflammatory activation and that myeloid 
cell-specific Per1ldc/Per2ldc disruption exacerbates HFD-induced inflammation and 
systemic metabolic dysregulation in chimeric mice repopulated with only mutant bone 
marrow cells (Xu et al., 2014). In our current study, circadian desynchronization in HFD-
fed mice exposed to shifted LD cycles essentially recapitulates the effects of genetic 
disruption of the core clock mechanism, inducing robust increases in macrophage 
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infiltration and proinflammatory activation in close correspondence with the 
intensification of metabolic phenotypes in diet-induced obesity. Collectively, these 
findings suggest that macrophage infiltration, proinflammatory activation and 
inflammatory signaling may be key processes in the mechanism by which genetic 
disruption and environmental desynchronization of circadian rhythms hinder metabolic 
homeostasis. 
Although our study and other literature indicate that increased proinflammation is a 
major feature found in genetic disruption and environmental desynchronization of 
circadian rhythms, how circadian disruption specifically triggers proinflammatory 
macrophage activation and inflammatory signaling cascades that lead to systemic 
metabolic dysregulation remains to be determined. Because chronic jet lag and shift work 
paradigms alter clock gene expression as well as phase alignment and amplitude of their 
rhythmic profiles (Filipski et al., 2004; Reddy et al., 2002; Yan, 2011), it is possible that 
core or auxiliary feedback loops comprising the circadian clockworks directly mediate the 
effects of circadian disruption on key elements of inflammatory signaling cascades such 
as NF-B, IL-6 and Ccl2 (Curtis et al., 2014). This speculation is supported by our 
previous observations indicating that myeloid cell-specific Per1 and Per2 disruption 
increased NF-B and JNK1 phosphorylation as well as IL-6 mRNA expression and 
decreased levels of PPAR, which promotes anti-inflammatory M2 activation, in 
macrophages isolated from HFD-fed mice (Xu et al., 2014). Direct involvement of core 
or auxiliary clock genes in linking circadian clock dysregulation with the potentiation of 
diet-induced inflammation is further suggested by studies demonstrating that: 1) CLOCK 
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upregulates NF-B activity (Spengler et al., 2012); and 2) REV-ERBα modulates 
macrophage Toll-like receptor (TLR) signaling (Fontaine et al., 2008) and inhibits 
proinflammatory IL-6 release (Gibbs et al., 2012). Thus, it will be important in future 
studies to determine whether blockade of inflammatory signaling via NF-B, IL-6 or 
downregulation of PPARameliorate the inductive effects of circadian disruption on diet-
associated metabolic dysregulation. Nevertheless, the present data provides primary 
evidence for the link between circadian clock dysregulation and macrophage 
proinflammatory activation in diet-induced metabolic dysfunction.  
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CHAPTER IV  
ROLE OF INFLAMMATORY SIGNALING IN THE DIFFERENTIAL EFFECTS OF 
SATURATED AND POLYUNSATURATED FATTY ACIDS ON PERIPHERAL 
CIRCADIAN CLOCKS*  
 
Introduction  
Over-nutrition, especially through the consumption of a HFD, is a critical factor in the 
rapidly increasing incidence of obesity. HFD-induced obesity is associated with systemic 
insulin resistance and the corresponding development of metabolic disorders such as type 
2 diabetes, cardiovascular disease and non-alcoholic fatty liver disease (Angulo, 2002; 
Hossain, Kawar, and El Nahas, 2007; Jensen et al., 2008). Increasing evidence indicates 
that chronic low-grade inflammation in peripheral tissues contributes to HFD-mediated 
obesity and insulin resistance. HFD increases plasma levels of saturated fatty acids, which 
can trigger pro-inflammatory responses through the induction of NF-κB and JNK 
signaling. Thus, the precise modulation of free fatty acid levels and inflammatory 
signaling are vital for the maintenance of metabolic homeostasis.  
Cell-autonomous circadian clocks in peripheral tissues are involved in the regulation 
of inflammatory responses and metabolic homeostasis. Endogenous clocks in immune 
cells provide for the circadian control of their abundance in the circulation, production of  
 
* Part of this chapter has been reprinted from Kim SM, Neuendorff N, Chapkin RS, Earnest 
DJ (2016) Role of Inflammatory Signaling in the Differential Effects of Saturated and 
Poly-unsaturated Fatty Acids on Peripheral Circadian Clocks. EBioMedicine 7: 100-11. 
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inflammatory factors, and functional responses to inflammatory challenge (Keller et al., 
2009; Lange et al., 2010). Tissue- and cell-specific clocks also provide for the local 
coordination of circadian rhythms in the metabolism of fatty acids (Stenvers et al., 2012). 
For example, circulating levels of free fatty acids and adipose tissue expression of genes 
mediating lipolysis and fatty acid biosynthesis or transport are characterized by clock-
controlled rhythmicity (Shostak et al., 2013). Moreover, genetic or environmental 
disruption of circadian clock function has been shown to potentiate inflammatory 
responses and to produce obesity and other metabolic disorders (Turek et al., 2005; 
Marcheva et al., 2010; Gibbs et al., 2012; Paschos et al., 2012). Our recent findings 
demonstrate that circadian clock disruption in bone marrow cells exacerbates HFD-
induced tissue inflammation, adiposity, and systemic insulin dysregulation (Xu et al., 
2014).  
While the hierarchy of circadian clocks throughout the body is clearly involved in 
regulating inflammatory and metabolic processes, this interaction is not strictly 
unidirectional as inflammatory signals and fatty acid metabolism have been conversely 
implicated in the feedback modulation of the circadian clock mechanism. In this regard, 
the cytokines TNF-α and IL-1β induce phase delays and HFD increases the free-running 
period of the activity rhythm in mice (Kohsaka et al., 2007; Leone et al., 2012; Xu et al., 
2014). Thus, mutual interactions between circadian clocks and key mediators of 
inflammation may be important in maintaining metabolic homeostasis and in linking clock 
dysregulation and metabolic phenotypes in diet-associated obesity. Because inflammatory 
responses and corresponding metabolic disturbances in diet-induced obesity are 
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differentially engaged by specific types of fatty acids found in HFDs, we compared the 
differential effects of palmitate, the prevalent pro-inflammatory SFA in HFD versus the 
anti-inflammatory, PUFA DHA on circadian clock function. The extent of the coupling 
between diet-mediated inflammatory responses and alterations in fundamental clock 
properties was examined by analyzing the phase-shifting effects of acute palmitate and 
DHA treatment at different times throughout the circadian cycle and then determining 
their coincidence with fatty acid-mediated induction of inflammatory signaling. To 
examine the role of inflammatory signaling in the mechanism by which SFAs modulate 
clock properties, experiments were also conducted to determine whether inhibition of pro-
inflammatory responses blocks palmitate-induced phase shifts of peripheral circadian 
clocks. 
 
Material and Methods 
Cell culture: Mouse Bmal1-dLuc fibroblasts (Dr. Andrew Liu, University of 
Memphis, Memphis, TN; Ramanathan et al., 2012) were propagated on 60mm dishes in 
Dulbeco’s Modified Eagle Medium (DMEM; HyClone) containing 292ug/mL L-
glutamine, 10% Fetal Bovine Serum (FBS), 100 units/ml penicillin, and 100 µg/ml 
streptomycin and maintained at 37°C and 5% CO2. Medium was replaced every 48hr and 
cultures were split 1:4 every 3 days. As established previously (Huo et al., 2010, 2012), 
adipocytes were differentiated from Bmal1-dLuc fibroblasts maintained in DMEM 
containing 10μg/ml insulin, 1μM dexamethasone, and 0.5mM 3-isobutyl-1-
methylxanthine for 48hr, and then incubated for 4 additional days in medium 
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supplemented with 10μg/ml insulin. Following differentiation, adipocytes were 
maintained for 2 days in normal growth medium prior to experimentation. Cell 
differentiation into adipocytes was verified by positive staining with oil red o (Figure 9A) 
and by upregulated expression of PPARγ and adiponectin (Figure 9B). While our analysis 
of these phenotypic markers indicates that Bmal1-dLuc fibroblasts exhibit many 
adipocyte-like properties following differentiation, it is unclear whether the cells are fully 
differentiated into mature adipocytes, thus warranting their subsequent designation as 
‘differentiated adipocytes’. 
 
Fatty acid/drug preparation and treatment: Palmitate (Sigma) and DHA (Nu-Chek-
Prep, Inc.) were dissolved in ethanol and then diluted (1:5.4 ratio) with 10% BSA (fatty 
acid-free and low endotoxin, Sigma A6003) diluted in 0.1M phosphate-buffered saline 
(PBS). Palmitate and DHA treatment in these studies was based on physiological 
concentrations that have been previously observed in vivo or used for in vitro studies 
(Ajuwon and Spurlock, 2005; Han and Liu, 2010; Puri et al., 2009; Weldon et al., 2007). 
Controls for fatty acid treatment contained BSA diluted in PBS with an equivalent ratio 
of ethanol. 
AICAR (Tocris) and cardamonin (Tocris) were dissolved in DMSO and then diluted 
1:400 and 1:10000 in culture medium to achieve final concentrations of 500uM or 5µM, 
respectively. Vehicle controls for AICAR and cardamonin treatment consisted of cultures 
in which an equivalent amount of DMSO was added to the medium. 
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Figure 9: Characterization of adipocyte phenotypes following differentiation of Bmal1-
dLuc fibroblasts. (A) Representative microscopic image illustrating the cytoplasmic 
accumulation of lipids in Bmal1-dLuc cells stained with oil red o staining after 
differentiation using the methods of Huo and colleagues (Huo et al., 2010b; Huo et al., 
2012). (B) Real-time PCR determinations (mean ± SEM) of PPARγ and adiponectin 
mRNA expression in Bmal1-dLuc fibroblast and differentiated adipocyte cultures. PPARγ 
(left panel) and adiponectin (right panel) mRNA signal were normalized to β-actin mRNA 
levels in each sample and the fold difference was determined by adjusting these values in 
relation to the average of undifferentiated fibroblast cultures, which was set at 1. The 
relative levels of PPARγ and adiponectin mRNA in differentiated adipocyte cultures were 
increased by 8-fold and 450-fold, respectively and were significantly greater (p<0.05) than 
that found in undifferentiated Bmal1-dLuc fibroblasts.  
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Effect of prolonged fatty acid treatment on circadian period: Bmal1-dLuc fibroblasts 
were plated onto 35mm dishes and ≈24hr later treated with either vehicle (EtOH with 10% 
BSA), palmitate (150µM), or DHA (150µM) for 48hr. Following fatty acid treatment, 
cultures were rinsed and then maintained in recording media for 6-7 days during real-time 
analysis of Bmal1-dLuc bioluminescence. 
The effects of prolonged palmitate treatment were also examined in vivo. Homozygous 
mPer2Luc knock-in mice (C57BL/6J background, male and female, 6 weeks old) were 
initially maintained on a 12:12-h light-dark cycle (lights on at 06:00) and fed ad libitum. 
To examine the effects of palmitate on circadian rhythms in vivo mice (5 – 6 weeks old) 
were anesthetized (ketamine -100mg/kg; /xylazine - 10 mg/kg body weight) and then an 
osmotic mini-pump (Alzet) containing BSA or 600mM palmitate was implanted 
subcutaneously posterior to the scapulae. Following mini-pump implantation, mice were 
maintained in constant darkness and the effects of palmitate infusion (0.15ul/hr-600mM) 
on the free-running period of the activity were analyzed for 6 weeks as previously 
described (Ko et al., 2011).  
 
Time-dependent variation in the phase shifting and pro-inflammatory effects of 
acute fatty acid treatment: Bmal1-dLuc fibroblast cultures on 35mm dishes were exposed 
for 2hr to medium containing 15uM forskolin to facilitate circadian oscillation 
synchronization across cultures (Menger et al., 2007) and then treated for 4hr with BSA 
(10% in EtOH), palmitate (250µM) or DHA (250µM) at 6hr intervals throughout the 
circadian cycle. Cultures were subjected to control or fatty acid treatments at 6, 12, 18 or 
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24hr after forskolin administration and then placed in recording media for 
bioluminescence analysis of treatment-induced phase shifts of Bmal1-dLuc oscillations.  
For parallel analyses of inflammatory responses to acute fatty acid treatment, confluent 
cultures of Bmal1-dLuc fibroblasts on 6-well plates were exposed for 2hr to 15uM 
forskolin and then 6, 12, 18 or 24hr later treated with BSA, palmitate (250µM) or DHA 
(250µM) for 4hr. After treatment, cells were rinsed, collected, frozen in liquid nitrogen 
and stored at -80°C for subsequent analyses of NF-κB activation or cytokine mRNA 
expression. 
The effects of acute palmitate treatment were also examined in vivo. Homozygous 
mPer2Luc knock-in mice (C57BL/6J background) were maintained under constant 
darkness and fed ad libitum. To examine the phase shifting effects of acute palmitate on 
circadian rhythms in vivo mice (5 – 10 weeks old) received intraperitoneal (i.p.) injection 
of either BSA or palmitate (100mg/kg) at CT 6, 12, 18 and 24. Following i.p. injection of 
BSA or palmitate, mice were maintained for 2 weeks in constant darkness until data 
analysis. Phase shifts of locomotor activity were determined by comparing the phase 
angles between pre-treatment and post-treatment of BSA or palmitate. Activity onset was 
used as phase reference point.  
 
Effect of inflammatory signaling inhibitors on fatty acid-induced phase shifts of the 
circadian clock: Real-time analysis of cells transfected with an inducible NF-kB-
responsive GFP construct was used to test whether treatment with DHA, AICAR, or 
cardamonin, a chalcone with anti-inflammatory activity (Ahmad et al., 2006), modulates 
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palmitate-induced inflammatory signaling when its phase-shifting effects are maximal. 
GFP-reported NF-κB activity was quantified in cells that were treated with: 1) DHA 
(50uM) for 12hr in advance and during exposure to palmitate (250µM) for 4hr; or 2) 
AICAR (500uM) or cardamonin (5µM) in conjunction with palmitate (250µM) 
administration for 4hr. Effects of these anti-inflammatory treatments on peak phase-
shifting responses of the Bmal1-dLuc rhythm were examined in parallel cultures that were 
similarly treated with DHA, AICAR or cardamonin relative to palmitate exposure at hour 
12. Following treatment, cultures were placed in recording media for bioluminescence 
analysis of treatment effects on palmitate-induced phase shifts of Bmal1-dLuc oscillations.  
 
Protein extraction and Western blot analysis of BMAL1 and NF-κB activation: 
Bmal1-dLuc fibroblasts were lysed in mammalian protein extraction reagent (Pierce 
Biotechnology) containing protease and phosphatase inhibitor cocktail (Thermo 
Scientific). Protein content in cell homogenates was measured using the bicinchoninic acid 
method. BMAL1, ACTIN, NF-κB and phospho-NF-κB in cell lysates (10-30ug 
protein/lane) were assessed by Western blot analysis using 10% Tris-Glycine gels as 
described previously (Shende et al., 2013). Membranes were probed with antibodies 
against BMAL1 (Cell Signaling Technology), ACTIN (Sigma), phospho-NF-κB (p-p65; 
Cell Signaling Technology) or NF-κB (p-65; Cell Signaling Technology) followed by 
incubation with horse-radish peroxidase-conjugated goat anti-rabbit IgG (Biorad). 
Densitometric analyses of size-appropriate immunoreactive bands were performed using 
NIH ImageJ software. To control for inter-sample differences in protein content, BMAL1 
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and p-NF-κB signal intensity were normalized to NF-κB and ACTIN values in each 
sample respectively. 
 
Real-time reporter assay of NF-κB activity: The Cignal NF-κB Reporter Assay Kit 
(Qiagen) was used to quantify treatment-induced changes in the transcriptional regulatory 
activity of NF-κB. Cultures of Bmal1-dLuc fibroblasts (70-80% confluent) on opaque 96-
well plates were transfected for 48hr with an inducible NF-kB-responsive GFP reporter 
construct (Qiagen) complexed with Lipofectamine® 3000 (Invitrogen). Approximately 
24hr after transfection, cells were exposed to medium containing 15uM forskolin and 12hr 
later treated with BSA (control) or palmitate for 4hr. Experimental groups included 
cultures treated with: 1) DHA (50uM) for 12hr in advance and during exposure to 
palmitate; or 2) AICAR (500uM) or cardamonin (5µM) in conjunction with palmitate 
administration. NF-κB signaling activity was assessed through quantitative measurement 
of GFP fluorescence and then compared relative to negative controls. 
 
RNA extractions and real-time PCR: Total RNA was extracted from all cell lysates 
and relative quantification of interleukin-6 (IL-6) mRNA abundance was performed using 
SYBR-Green PCR technology [Applied Biosystems Inc. (ABI)] as described previously 
(Farnell et al., 2011; Xu et al., 2014). For each sample, real-time PCR analysis of IL-6 
mRNA was performed on duplicate aliquots using the cDNA equivalent of 1ng of total 
RNA. To control for differences in sample RNA content, β-actin mRNA was amplified 
with the cDNA equivalent of 1ng total RNA from the same samples. Consistent with our 
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previous studies (Xu et al., 2014), β-actin mRNA showed no sign of circadian variation. 
The comparative CT method was utilized to calculate the relative abundance for a given 
cytokine mRNA by normalization to corresponding β-actin levels in each sample and to a 
calibrator consisting of pooled cDNA from multiple samples. 
 
Real-time analysis of Bmal1-dLuc rhythms: Prior to bioluminescence analysis, 
growth medium was removed and cultures were placed in DMEM recording medium 
containing 1uM forskolin, 25mM HEPES, 292µg/ml L-glutamine, 100units/ml penicillin, 
100μg/ml streptomycin and 10uM luciferin (Promega). Cultures were sealed airtight with 
sterile glass coverslips, and sterile silicon grease. The temporal patterns of Bmal1-dLuc 
bioluminescence were analyzed using an automated 32-channel luminometer (LumiCycle; 
Actimetrics) housed in a standard culture incubator at 32°C. Bioluminescence from 
individual cultures was continuously recorded for ~70sec at intervals of 10min. Rhythm 
parameters were determined from baseline-subtracted data using the damped sine fit and 
Levenberg–Marquardt algorithm. The amplitude of phase shifts in response to fatty acid 
treatment was determined by measuring the time difference between the peaks of the 
Bmal1-dLuc rhythms during the third cycle in BSA or BSA/vehicle (DMSO) control and 
experimental treatment groups. 
 
Statistical analysis: Independent t-tests were performed to determine the significance 
of treatment effects (DHA, palmitate, AICAR, or cardamonin relative to vehicle controls) 
on NF-κB activity, IL-6 expression and palmitate-induced phase shifts. In each case, the 
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p-value was set at 0.05. Time-dependent differences in phase-shifting effects of DHA or 
palmitate on the Bmal1-dLuc rhythm were first analyzed by one-way analysis of variance 
(ANOVA). Paired comparisons between peak phase-shifting responses and the 
corresponding minima were analyzed post hoc for statistical differences using the Student 
Newman-Keuls sequential range test. The p-value was set at 0.05 for these post hoc 
analyses. 
 
Results 
Effect of prolonged fatty acid treatment on circadian period: Given that HFD feeding 
induces pronounced alterations in circadian timekeeping in peripheral clocks (Xu et al., 
2014), we first determined whether prolonged treatment with palmitate, the prevalent SFA 
in HFD, similarly affects clock gene oscillations in Bmal1-dLuc fibroblasts in vitro. All 
BSA-, DHA- and palmitate-treated fibroblast cultures exhibited circadian rhythms of 
Bmal1-dLuc bioluminescence that persisted at least 4-5 cycles (Figure 10). The period of 
the Bmal1-dLuc rhythms in cultures exposed to DHA for 48hr was greater (by ≈0.4hr) but 
not significantly different (p=0.14) relative to that observed in BSA-treated controls 
(Figure 10A). In contrast, palmitate-treated fibroblast cultures were distinguished by 
Bmal1-dLuc rhythms in which the period was significantly increased (p>0.05) by ≈3 hours 
in comparison to BSA controls (Figure 10B). Palmitate treatment also had a distinct effect 
in reducing rhythm amplitude to ≈40% of control values.  
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Figure 10: Effects of prolonged PUFA and SFA treatment on ensemble Bmal1-dLuc 
rhythms in cultured fibroblasts. Individual recordings of ensemble bioluminescence 
(expressed as detrended baseline-subtracted counts per second) from representative 
cultures of Bmal1-dLuc fibroblasts treated with: (A) BSA (n=6) or 150µM DHA (n=8), 
and (B) BSA (n=6) or 150µM palmitate (n=8). Bar graphs depict comparisons of the 
circadian period (mean + SEM) of the Bmal1-dLuc rhythms in BSA control and DHA- 
or palmitate-treated fibroblasts. Asterisk indicates that the period of the Bmal1-dLuc 
rhythms in palmitate-treated cultures was significantly greater (p<0.05) than that in BSA 
controls.  
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Prolonged palmitate treatment in vivo had a similar effect on the circadian period of 
the rhythm in mouse wheel-running behavior, except its amplitude was much smaller than 
that observed on fibroblast Bmal1-dLuc rhythms. During palmitate infusion via osmotic 
mini pump (0.15ul per hour, 600mM) for 6 weeks, the free-running period of the activity 
rhythm was significantly increased (p>0.05) by ≈0.5hr in comparison with BSA-treated 
control mice (Figure 11A). Importantly, this palmitate-induced increase in circadian 
period in vivo was accompanied by corresponding increases in circulating levels of free 
fatty acids (Figure 11B). In palmitate-infused mice, serum levels of free fatty acids were 
significantly elevated (p>0.05) by about 1.7 fold relative to BSA controls.  
 
Time-dependent variation in the phase shifting and pro-inflammatory effects of 
acute fatty acid treatment: In response to acute (4hr) treatment at hour 6, 12, 18 and 24 
with 250µM DHA or palmitate, the period of the Bmal1-dLuc rhythms in cultures of 
undifferentiated fibroblasts was not significantly different from that observed in 
experiment-matched BSA controls. Phase shifting analysis revealed that DHA had 
negligible effects on the Bmal1-dLuc rhythm at hour 6 and 24 whereas treatment at hour 
12 and 18 induced small phase delays of about 0.5hr (Figure 12). Following 
bioluminescence analysis, no differences in cell viability were evident in cultures treated 
with 250µM DHA. Similar to DHA, acute palmitate treatment shifted the phase of 
fibroblast Bmal1-dLuc rhythms in a time-dependent manner, but the directionality of these 
shifts was different and their amplitude was much larger (Figure 13). At hour 12 and 18   
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Figure 11: Effect of prolonged SFA treatment on the free-running rhythm of locomotor 
activity in vivo. (A) Representative records of wheel-running activity in BSA- or PAL-
treated mice. Actograms are plotted over a 24-hour period. The open and closed bars at 
the top respectively signify the timing of the light and dark phase during initial entrainment 
to LD 12:12. At the arrow on the actograms, animals were implanted with an osmotic 
mini-pump infusing BSA or palmitate (0.15ul/hr-600mM) and then exposed to constant 
darkness. Bar graph depicts average free-running period of the activity rhythm (±SEM) in 
BSA- and PAL-treated mice during exposure to constant darkness. *, P < 0.05, BSA vs. 
PAL (B) Serum levels of free fatty acids in mice during BSA or PAL infusion. Bars 
represent mean values (± SEM). *, P < 0.05, BSA vs. PAL.  
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Figure 12: Phase-shifting effects of acute DHA treatment on ensemble Bmal1-dLuc 
rhythms in cultured fibroblasts. (A) Representative recordings of ensemble 
bioluminescence from individual cultures of Bmal1-dLuc fibroblasts treated for 4hr with 
BSA (n=4) or 250µM DHA (n=8) at hour 6, 12, 18 and 24. Red arrows indicate time of 
BSA or DHA treatment. (B) Time-dependent phase shifts of fibroblast Bmal1-dLuc 
rhythms in response to DHA treatment for 4hr. Mean (+SEM) phase shifts () in hours 
are plotted as a function of the timing of DHA treatment (at hour 6, 12, 18 and 24). 
Phase delays of the fibroblast Bmal1-dLuc rhythm are indicated by negative values and 
advances are denoted by positive values. Asterisks indicate that phase-shifting responses 
to DHA at hour 12 and 18 were significantly greater (p<0.05) than those observed during 
the corresponding minima.  
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Figure 13: Phase-shifting effects of acute palmitate (PAL) treatment on ensemble Bmal1-
dLuc rhythms in cultured fibroblasts. (A) Representative recordings of ensemble 
bioluminescence from individual cultures of Bmal1-dLuc fibroblasts treated for 4hr with 
BSA (n=5-6) or 250µM PAL (n=5-6) at hour 6, 12, 18 and 24. Red arrows indicate time 
of BSA or PAL treatment. (B) Time-dependent phase shifts (mean ± SEM) of fibroblast 
Bmal1-dLuc rhythms in response to PAL treatment at hour 6, 12, 18 and 24. The asterisk 
indicates that peak phase-shifting responses to PAL at hour 12 were significantly greater 
(p<0.05) than those observed during the corresponding minima.  
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when DHA induced small phase delays, palmitate produced the opposite effect: phase 
advances of fibroblast Bmal1-dLuc rhythms. Peak phase-shifting responses to palmitate 
were observed at hour 12 when treatment induced large phase advances of ≈2.5 hours. 
Palmitate treatment at hour 18 also produced clear phase advances of the Bmal1-dLuc 
rhythm although the amplitude (≈1hr) was reduced relative to its phase-shifting effects at 
hour 12. Palmitate-induced phase shifts were minimal at hour 6 and 24, with treatment 
inducing small advances and delays of ≈0.5hr respectively at these timepoints. Unlike 
prolonged exposure, acute treatment with DHA or palmitate had little or no consistent 
effect on the amplitude of the Bmal1-dLuc rhythm. 
To determine whether DHA or palmitate phase shift clock gene rhythms in other 
peripheral cell types and whether the time-dependent nature of phase-shifting responses 
differs among peripheral circadian clocks, parallel analysis was performed on adipocytes 
differentiated from Bmal1-dLuc fibroblasts. Irrespective of treatment time, DHA had little 
or no phase-shifting effects on the Bmal1-dLuc rhythm in differentiated adipocytes (Figure 
14). DHA produced small phase advances (≈0.25hr) at hour 6 and phase delays (≈0.2hr) 
at hour 12 whereas phase-shifting effects of this PUFA were marginal (<0.1hr) at hour 18 
and 24. Similar to its effects on undifferentiated fibroblasts, acute palmitate treatment 
shifted the phase of adipocyte Bmal1-dLuc rhythms (Figure 15). However, the time-
dependent variation in adipocyte phase-shifting responses to palmitate was markedly 
different from the pattern in undifferentiated fibroblasts. Palmitate-induced phase shifts in 
differentiated adipocytes were maximal at hour 6, when treatment had negligible effects 
on the phase of undifferentiated fibroblast Bmal1-dLuc rhythms. At hour 6, palmitate   
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Figure 14: Phase-shifting effects of acute DHA treatment on ensemble Bmal1-dLuc 
rhythms in cultures of differentiated adipocytes. (A) Representative recordings of 
ensemble bioluminescence from individual cultures of differentiated Bmal1-dLuc 
adipocytes treated for 4 hours with BSA (n=4) or 250µM DHA (n=5-10) at hour 6, 12, 18 
and 24. Red arrows indicate the approximate time at which cultures were exposed to BSA 
or DHA. (B) Time-dependent phase shifts (mean ± SEM) of adipocyte Bmal1-dLuc 
rhythms in response to DHA treatment at hour 6, 12, 18 and 24.  
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Figure 15: Phase-shifting effects of acute palmitate (PAL) treatment on ensemble Bmal1-
dLuc rhythms in cultures of differentiated adipocytes. (A) Representative recordings of 
ensemble bioluminescence from individual cultures of differentiated Bmal1-dLuc 
adipocytes treated for 4hr with BSA (n=6) or 250µM PAL (n=6) at hour 6, 12, 18 and 24. 
Red arrows indicate time of BSA or PAL treatment. (B) Time-dependent phase shifts 
(mean ± SEM) of adipocyte Bmal1-dLuc rhythms in response to PAL treatment for at hour 
6, 12, 18 and 24. The asterisk indicates that peak phase-shifting responses to PAL at hour 
6 were significantly greater (p<0.05) than those observed during the corresponding 
minima.  
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advanced the phase of adipocyte Bmal1-dLuc rhythms by ≈4hr. In differentiated adipocyte 
cultures, palmitate also induced small phase advances (≈1.3hr) at hour 12 but had minimal 
effects on the Bmal1-dLuc rhythm at hour 18 and 24, producing phase delays of less than 
0.7hr. Bmal1-dLuc rhythms in differentiated adipocytes showed no clear signs of DHA- 
or palmitate-induced changes in amplitude. Acute palmitate treatment in vivo induced 
small phase shifts in locomotor activity rhythms, but its effects were not significant over 
all time points (Figure 16).  
Since SFAs trigger NF-κB-mediated signaling that leads to the induction of pro-
inflammatory cytokines (Ajuwon and Spurlock, 2005; Maloney et al., 2009; Wang et al., 
2012), we next determined whether the effects of palmitate on these key mediators of fatty 
acid-induced inflammation are both time-dependent and coincident with the temporal 
variation in the phase-shifting responses of the clock mechanism to this SFA. Consistent 
with previous reports (Gladine et al., 2014; Novak et al., 2003), acute DHA treatment had 
no effect on NF-κB activation but modulated expression of the pro-inflammatory cytokine 
IL-6 in Bmal1-dLuc fibroblasts. In cultures treated with DHA at hour 6, 12, 18 or 24, 
levels of NF-κB phosphorylation (Figure 17A) were not significantly different from those 
in time-matched BSA controls. However, DHA administration at hour 12, 18 and 24 
induced significant decreases (p<0.05) in IL-6 mRNA expression (≈40-75%) relative to 
BSA-treated fibroblasts (Figure 17B). In contrast to DHA, palmitate induced both NF-κB 
signaling and IL-6 mRNA expression in Bmal1-dLuc fibroblasts in a time-dependent 
manner. Relative to BSA-treated cultures, palmitate induced significant increases 
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Figure 16: Phase shifting effect of acute palmitate (PAL) treatment on the free-running 
rhythm of locomotor activity in vivo. (A) Representative records of wheel-running activity 
in BSA- or PAL-treated mice under constant darkness. Actograms are plotted over a 48-
hour period. At the arrow on the actograms, animals were received i.p. injection of BSA 
or palmitate (100mg/kg). (B) Time-dependent phase shifts (mean ± SEM) of locomotor 
activity rhythms in response to BSA or PAL treatment for at CT 6, 12, 18 and 24.    
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Figure 17: Time-dependent effects of acute DHA treatment on inflammatory signaling in 
Bmal1-dLuc fibroblasts. (A) Representative Western blots and densitometric analyses of 
NF-κB-mediated inflammatory signaling in fibroblast cultures treated for 4hr with BSA 
(n=3) or 250µM DHA (n=3) at hour 6, 12, 18 and 24. Bar graphs depict the ratios of P-
p65/p65 immunoreactive signal that were adjusted in relation to control (BSA) values (% 
Control). (B) Real-time PCR determinations (mean ± SEM) of IL-6 mRNA expression in 
parallel groups of BSA- and DHA-treated fibroblast cultures. Plotted values correspond 
to the ratio of IL-6 mRNA signal normalized to β-actin mRNA levels in each sample and 
adjusted relative to the averages of time-matched BSA controls, which were set at 100%. 
Asterisks denote treatment times in which the relative expression of IL-6 mRNA in DHA-
treated fibroblasts was significantly decreased (p<0.05) in comparison with that found in 
BSA controls.  
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(p<0.05) in NF-κB phosphorylation at hour 12 and 18 but not at hour 6 and 24 (Figure 
18A), coinciding with the temporal variation in the amplitude of phase-shifting responses 
to this SFA. Palmitate-induced IL-6 expression in Bmal1-dLuc fibroblasts provided 
further evidence of the close temporal coincidence between proinflammatory and phase-
shifting responses to treatment; in palmitate-treated cultures, IL-6 mRNA expression was 
significantly increased (p<0.05) by 180-225% at hour 12 and 18 relative to BSA controls 
but this inductive effect was blunted (≈135%) at hour 6 and 24 (Figure 18B). 
The effects of acute DHA treatment on NF-κB activation and IL-6 expression in 
differentiated adipocytes were similar to those observed in undifferentiated fibroblasts. 
Following administration at hour 6, 12, 18 and 24, DHA-treated adipocyte cultures and 
time-matched BSA controls exhibited no significant differences in levels of NF-κB 
phosphorylation (Figure 19A). However, IL-6 mRNA expression was significantly 
decreased (p<0.05) by ≈60-70% in response to DHA administration at hour 12, 18 and 24 
relative to that observed in BSA-treated adipocytes (Figure 19B). At hour 6, IL-6 mRNA 
expression in DHA-treated cultures was decreased but not significantly different in 
comparison to time-matched controls. In differentiated adipocytes, palmitate treatment 
produced time-dependent increases in both NF-κB activation and IL-6 mRNA expression. 
Peak induction of NF-κB phosphorylation was observed in response to palmitate 
administration at hour 6 (Figure 20A), when phase-shifting responses to this SFA were 
maximal in differentiated adipocytes. Relative to time-matched BSA controls, palmitate  
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Figure 18: Time-dependent effects of acute palmitate (PAL) treatment on inflammatory 
signaling in Bmal1-dLuc fibroblasts. (A) Representative Western blot and densitometric 
quantification (mean ± SEM) of P-p65/p65 immunoreactive signal (% Control) in 
fibroblast cultures treated for 4hr with BSA (n=3) or 250µM PAL (n=3) at hour 6, 12, 18 
and 24. (B) IL-6 mRNA expression (mean ± SEM) in parallel groups of BSA- and PAL-
treated fibroblast cultures. Asterisks denote treatment times in which NF-κB 
phosphorylation or the relative expression of IL-6 mRNA in PAL-treated fibroblasts were 
significantly increased (p<0.05) compared to that found in control cultures. 
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Figure 19: Time-dependent effects of acute DHA treatment on inflammatory signaling in 
differentiated Bmal1-dLuc adipocytes. (A) Representative Western blots and 
densitometric quantification (mean ± SEM) of P-p65/p65 immunoreactive signal (% 
Control) in differentiated adipocyte cultures treated for 4hr with BSA (n=3) or 250µM 
DHA (n=3) at hour 6, 12, 18 and 24. (B) Determinations (mean ± SEM) of IL-6 mRNA 
expression in parallel groups of BSA- and DHA-treated differentiated adipocyte cultures. 
Asterisks denote treatment times in which the relative expression of IL-6 mRNA in DHA-
treated differentiated adipocytes was significantly decreased (p<0.05) in comparison with 
that found in BSA controls. 
  
 82 
 
 
Figure 20: Time-dependent effects of acute palmitate (PAL) treatment on inflammatory 
signaling in differentiated Bmal1-dLuc adipocytes. (A) Representative Western blots and 
densitometric quantification (mean ± SEM) of P-p65/p65 immunoreactive signal (% 
Control) in differentiated adipocyte cultures treated for 4hr with BSA (n=3) or 250µM 
PAL (n=3) at hour 6, 12, 18 and 24. (B) IL-6 mRNA expression (mean ± SEM) in parallel 
groups of BSA- and PAL-treated differentiated adipocyte cultures. Asterisks denote 
treatment times in which NF-κB phosphorylation or the relative expression of IL-6 mRNA 
in PAL-treated differentiated adipocytes were significantly increased (p<0.05) compared 
to that found in control cultures.  
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induced significant increases (p<0.05) in NF-κB activation not only at hour 6 but also at 
hour 24. NF-κB phosphorylation in palmitate-treated adipocyte cultures was moderately 
elevated at hour 12 but unchanged at hour 18 in comparison with the levels observed in 
BSA controls. The effects of palmitate on IL-6 expression in differentiated adipocytes 
closely coincided with the timing of peak phase-shifting responses to this SFA. Palmitate 
had no significant effect on IL-6 mRNA levels following administration at hour 12, 18 
and 24 (Figure 20B) but significantly increased (p<0.05) expression of this pro-
inflammatory cytokine (≈188%) at hour 6, when treatment induced maximal phase 
advances of adipocyte Bmal1-dLuc rhythms. 
 
Effect of inhibiting inflammatory signaling on fatty acid-induced phase shifts of the 
circadian clock: To examine the role of inflammatory signaling in the mechanism by 
which palmitate modulates circadian clock function, we next determined whether the 
omega-3 fatty acid DHA and other inhibitors of inflammation abate peak inflammatory 
and phase-shifting responses to this SFA at hour 12 in Bmal1-dLuc fibroblasts. Because 
AMPK plays a role in regulating fatty acid oxidation and inhibiting NF-κB-mediated 
inflammatory responses (Salminen et al., 2011), the AMPK activator, AICAR, was 
utilized in parallel to inhibit palmitate-induced inflammatory signaling. Consistent with 
previous reports on AMPK regulation in response to palmitate and other SFAs (Lindholm 
et al., 2013; Sun et al., 2008), phospho-AMPK activity was significantly decreased 
(p<0.05) in Bmal1-dLuc fibroblasts treated with palmitate and was significantly increased   
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(p<0.05) following exposure to AICAR alone (Figure 21). Palmitate administration at 
hour 12 induced a 35-40% increase in GFP-reported NF-κB activation in Bmal1-dLuc 
fibroblasts, but treatment with DHA (Figure 22A), AICAR (Figure 22B) or cardamonin 
(Figure 22C) significantly inhibited (p<0.05) the inductive effects of this SFA on NF-κB 
such that signaling activity was comparable to the basal levels found in BSA/vehicle 
controls. Treatment with DHA, AICAR or cardamonin similarly inhibited the phase-
shifting responses of Bmal1-dLuc fibroblasts to palmitate. In DHA-treated cultures, 
palmitate-induced phase shifts of the Bmal1-dLuc rhythm were significantly decreased 
(p<0.05) relative to those observed in controls (Figure 23A). Administration of palmitate 
alone produced 2.5-hour phase advances in vehicle-pretreated controls whereas the 
amplitude of these shifts was reduced by 70% following pretreatment with DHA. Little or 
no phase-shifting effect was observed in response to DHA alone (+BSA at hour 12). 
Similar to the effects of DHA, AICAR significantly decreased (p<0.05) the phase-shifting 
responses of fibroblast Bmal1-dLuc rhythms to palmitate administration at hour 12 (Figure 
23B). Once again, palmitate alone induced large phase advances of ≈2.8hr in vehicle-
pretreated cultures. In comparison, the amplitude of these palmitate-induced phase shifts 
was abated by ≈80% in AICAR-treated fibroblasts. Phase-shifting effects of AICAR alone 
were minimal as only small advances of the Bmal1-dLuc rhythm (<0.5hr) were observed 
in cultures treated with BSA and AICAR at hour 12. Concurrent treatment with 
cardamonin, an anti-inflammatory chalconoid that inhibits LPS-stimulated NF-κB 
signaling (Chow et al., 2012), also had a significant effect (p<0.05) in repressing 
palmitate-induced phase shifts of fibroblast Bmal1-dLuc rhythms at hour 12. Palmitate  
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Figure 21: Effects of palmitate (PAL) and AICAR treatment on phospho-AMPK activity 
in Bmal1-dLuc fibroblasts.  Using an ELISA assay for phospho-AMPKα (Invitrogen), p-
AMPK activity was analyzed in cultures treated with AICAR (500uM) in conjunction with 
palmitate (250µM) administration. Effects of treatment with PAL (VEH+PAL) or AICAR 
(AICAR+BSA) alone on p-AMPK activity were also tested. Control cultures were treated 
with vehicle (DMSO) and BSA (VEH+BSA). Plotted values denote determinations of 
colorometric signal intensity (mean ± SEM) in each treatment group (n=4) that were 
normalized to the average signal for controls, which was arbitrarily set at 100%. Phospho-
AMPK activity was significantly decreased (p<0.05) in Bmal1-dLuc fibroblasts treated 
with PAL (VEH+PAL) and was significantly increased (p<0.05) in cultures treated with 
AICAR alone (AICAR+BSA) relative to that found in controls (VEH+BSA).  
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Figure 22: Effects of DHA (A), AICAR (B) or cardamonin (C) treatment on NF-κB-
regulated inflammatory responses of Bmal1-dLuc fibroblasts to palmitate (PAL; 250µM).  
Bar graphs depict real-time fluorometric analysis of cells transfected with an inducible 
NF-κB-responsive GFP construct that were treated with DHA (50uM), AICAR (500uM) 
or cardamonin (5µM) in advance of and/or during palmitate (250µM) administration for 
4hr at hour 12. Effects of treatment with DHA, AICAR or cardamonin alone (DHA+BSA, 
AICAR+BSA, CARD+BSA) on NF-κB activity were also tested. Control cultures were 
treated with BSA or vehicle (DMSO) and BSA (VEH+BSA). Plotted values denote 
determinations of GRP signal intensity (mean ± SEM) in each treatment group (n=5) that 
were normalized to the average signal for controls, which was arbitrarily set at 100%. 
Asterisks indicate that palmitate-induced NF-κB activity was significantly decreased 
(p<0.05) in Bmal1-dLuc fibroblasts treated with DHA (DHA+PAL), AICAR 
(AICAR+PAL) or cardamonin (CARD+PAL) in comparison with those exposed to 
palmitate alone (BSA+PAL or VEH+PAL).  
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Figure 23:  Effects of DHA (A), AICAR (B) or cardamonin (C, CARD) treatment on the 
phase-shifting responses of Bmal1-dLuc fibroblasts to palmitate (PAL). Representative 
recordings of ensemble bioluminescence from individual fibroblast cultures treated with 
either vehicle (VEH; DMSO), DHA (50µM) for 12hr in advance or AICAR (500µM) or 
cardamonin (5µM) for 4hr in conjunction with PAL administration (250µM) for 4hr at 
hour 12. Phase-shifting effects of these anti-inflammatory treatments alone were also 
tested in BSA control cultures treated with DHA for 12hr, or with AICAR or cardamonin 
for 4hr. Specific experimental groups include: BSA+BSA or VEH+BSA (n=15), 
BSA+PAL or VEH+PAL (n=18), DHA+PAL (n=6), DHA+BSA (n=6), AICAR+PAL 
(n=10), AICAR+BSA (n=8), CARD+PAL (n=6) and CARD+BSA (n=6). Red arrows 
denote time of palmitate administration after 12hr pretreatment with DHA (adjacent 
shaded area in A) or during AICAR (B) or cardamonin treatment (C). Bar graphs depict 
the mean (±SEM) phase shifts () in hours as a function of treatment group. Asterisks 
indicate that palmitate-induced phase shifts were significantly decreased (p<0.05) in 
Bmal1-dLuc fibroblasts treated with DHA (DHA+PAL), AICAR (AICAR+PAL) or 
cardamonin (CARD+PAL) in comparison with those observed in controls (VEH+PAL).  
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induced phase advances of ≈2 hours in vehicle-treated cultures but only advanced Bmal1-
dLuc rhythms by 0.5hr or less in cultures concurrently treated with cardamonin (Figure 
23C). Treatment with cardamonin alone (+BSA at hour 12) induced small phase delays 
(≈1hr). 
 
Additional Results 
Because acute palmitate induced time-dependent phase shifts of Bmal1-dLuc rhythm, 
we determined whether expression of core clock component BMAL1 protein is also 
altered by acute palmitate treatment in a time-dependent manner. Consistent with the time-
dependent variation in its phase shifting effects on Bmal1- dLuc rhythms, palmitate 
treatment at hour 12 and 18, but not at hour 6 and 24, significantly increased (p<0.05) 
BMAL1 protein levels in fibroblast cultures (Figure 24).  
Since AMPK is an energy-sensing enzyme that influences downstream inflammatory 
signaling pathway (Fullerton et al., 2013), we determined whether AMPK activity is 
regulated in a circadian manner. Wild-type fibroblast cultures exhibited circadian rhythms 
in phospho-AMPK levels with peak activity at hour 12 (after serum shock), but this 
rhythm was abolished in Per1ldc/Per2ldc fibroblasts (Figure 25) indicating that AMPK 
activity is under the direct regulation of the fibroblast clock mechanism. Interestingly, the 
peak of AMPK phosphorylation coincided with the specific time when phase-shifting and 
proinflammatory effects of palmitate were maximal. Because palmitate decreases AMPK 
activity (Sun et al., 2008) and AMPK is directly involved in the regulation of core clock   
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Figure 24: Time-dependent effects of acute palmitate (PAL) treatment on BMAL1 protein 
levels in Bmal1-dLuc fibroblasts. Representative Western blots and densitometric 
analyses of BMAL1 in fibroblast cultures treated for 4hr with BSA (n=3) or 250µM PAL 
(n=3) at hour 6, 12, 18 and 24. Bar graphs depict the ratios of BMAL1/ACTIN 
immunoreactive signal that were adjusted in relation to control (BSA) values (% Control). 
Asterisks denote treatment times in which BMAL1 protein levels in PAL-treated 
fibroblasts were significantly increased (p<0.05) compared to that found in control 
cultures. 
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Figure 25: Circadian rhythm of phospho-AMPK protein (Molecular weight: 62 kDa) 
levels in wild-type and Per1ldc/Per2ldc fibroblasts. Representative Western blots and 
densitometric quantification (mean ± SEM) of p-AMPK immunoreactive signal (ratio of 
phospho-AMPK normalized to total AMPK) in wild-type (WT) (n=3) and Per1ldc/Per2ldc 
(n=3) fibroblasts collected at 4hr intervals for 28hr. 
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machinery (Lamia et al., 2009), we predict that palmitate treatment may suppress peak 
AMPK activity at hour 12, and thus yield maximal phase shifts. At hour 6, 18 and 24, 
palmitate may have a minor effect on AMPK activity because fibroblast AMPK activity 
is already low, thereby producing small phase shifts in response to this SFA. Taken 
together, these observations suggest that the rhythm in AMPK activity may play a role in 
the time-dependent phase shifts of the fibroblast clock in response to palmitate. This 
speculation may also apply to our AICAR data; this AMPK activator AICAR may 
attenuate palmitate-induced phase shifts by reversing the inhibitory effects of this SFA 
and restoring AMPK activity to peak levels that normally occur at hour 12. Circadian 
clocks in many peripheral tissues/cells of mammals coordinate daily rhythms in 
inflammatory responses, nutrient metabolism and secretion 
 
Discussion 
While circadian clocks throughout the body clearly play a role in regulating metabolic 
pathways and their homeostatic function, increasing evidence for diet-induced alterations 
in clock gene oscillations and behavioral rhythms suggests that nutrient metabolism may, 
in turn, feed back on the clock mechanism and modulate fundamental properties of 
circadian rhythms. HFD has been to alter circadian timekeeping function although its 
effects vary greatly among clocks in the brain and peripheral tissues. For example, HFD 
had no effect on core clock gene oscillations in the hypothalamus and only produced small 
increases in the free-running period of the SCN-regulated rhythm of locomotor activity 
(Kohsaka et al., 2007; Xu et al., 2014). Consistent with the effects of HFD on circadian 
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clocks in the brain, palmitate alters clock gene expression and the amplitude of their 
rhythmic profiles in a hypothalamic cell line and this effect is not accompanied by a 
corresponding induction of inflammatory cytokines such as IL-6 (Fick et al., 2011; Greco 
et al., 2014).  In contrast, HFD-induced dysregulation of circadian timekeeping is more 
robust in peripheral clocks; in HFD-fed mice, clock gene oscillations are distinguished by 
severe damping in both liver and fat tissue (Kohsaka et al., 2007) and by circadian period 
increases of up to 9hr in adipose tissue and bone marrow-derived macrophages (Xu et al., 
2014). Similar to the latter effect of HFD, prolonged treatment with palmitate induced 
large increases in the period of fibroblast Bmal1-dLuc rhythms, but small increases in the 
free-running period of the SCN-regulated rhythm in locomotor activity, suggesting that 
this pro-inflammatory SFA is a key mediator of HFD-induced modulation of peripheral 
circadian clocks. 
Importantly, our findings indicate that the effects of HFD and its major constituent, 
palmitate, on circadian clock properties are not limited to changes in period and rhythm 
amplitude, but include differential phase shifts of clock gene oscillations in peripheral 
tissues. Previous studies have established that phase-shifting responses to HFD again 
differ among peripheral and central circadian clocks. In this regard, HFD treatment for 7 
days has been shown to shift Per2 oscillations, producing large advances in the liver and 
small delays in the spleen but no effect on the phase of SCN rhythms (Pendergast et al., 
2013). In the present study, 4-hour exposure of peripheral cell types to palmitate similarly 
induced marked phase shifts of clock gene oscillations that varied in amplitude depending 
on the time of treatment. It is noteworthy that the time-dependent nature of palmitate-
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mediated phase shifts of the Bmal1-dLuc rhythm was cell-specific; the phase responses of 
undifferentiated fibroblasts to this pro-inflammatory SFA were maximal at hour 12 and 
negligible at hour 6 when palmitate-induced phase advances were at peak amplitude in 
differentiated adipocytes. Because the omega-3 fatty acid DHA had little or no phase-
shifting effects on clock gene oscillations in both fibroblasts and differentiated adipocytes, 
these findings collectively suggest that SFAs may differentially reset the clock mechanism 
in some but not all cells within a given tissue, thereby altering the local coordination of 
circadian timekeeping among individual cellular clocks. 
How HFD and palmitate modulate circadian timekeeping is unknown. The present 
evidence for the close coincidence between the time-dependent variation in inflammatory 
and phase-shifting responses to palmitate raises the possibility that mutual interactions 
between peripheral circadian clocks and inflammatory signaling pathways may play a key 
role in the underlying mechanism. In both Bmal1-dLuc fibroblasts and differentiated 
adipocytes, the maxima and minima for palmitate-induced inflammatory signaling were 
contemporaneous with the equivalent variation in the amplitude of the phase shifts induced 
by this SFA. Thus, the signaling cascades through which HFD and SFAs induce 
inflammation in peripheral tissues may govern the modulatory effects of palmitate on 
circadian timekeeping. The induction of inflammatory signaling by palmitate and other 
SFAs is mediated through activation of NF-κB, ultimately leading to the secretion of pro-
inflammatory cytokines in various peripheral tissues (Ajuwon and Spurlock, 2005; Jove 
et al., 2006; Weigert et al., 2004). In addition, the nutrient sensor, AMP-activated protein 
kinase (AMPK), is involved in coupling fatty acid metabolism to inflammatory responses. 
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Palmitate and other SFAs decrease AMPK activity (Sun et al., 2008; Lindholm et al., 
2013) and correspondingly their inductive effects on NF-κB activation and the expression 
of pro-inflammatory cytokines are repressed by AMPK activators (Green et al., 2011; 
Yang et al., 2010). The role of inflammatory signaling in SFA-mediated phase regulation 
of peripheral circadian clocks is directly supported by the present findings that the anti-
inflammatory inhibitor of NF-κB signaling, cardamonin, and the AMPK activator, 
AICAR, suppress peak induction of both inflammatory and phase-shifting responses to 
palmitate at hour 12. Because DHA represses inflammation-induced NF-κB signaling and 
cytokine expression via activation of AMPK (Xue et al., 2012), the observed inhibition of 
palmitate-induced inflammation and phase shifts following pretreatment with this PUFA 
also underscores the importance of clock-gated inflammatory signaling in the mechanism 
by which palmitate alters circadian timekeeping. In conjunction with evidence for the 
circadian regulation of AMPK activity (Um et al., 2011) and inflammatory responses of 
the NF-κB pathway (Spengler et al., 2012) in different tissues, these observations indicate 
that mutual interactions between peripheral clocks and inflammatory signaling mediate 
the time-dependent variation in the extent to which SFA overload triggers inflammation 
and in turn, leads to the feedback modulation of circadian timekeeping. 
The endoplasmic reticulum (ER) stress pathway may also be involved in the palmitate-
mediated regulation of circadian clock properties. Recent evidence supports a link 
between the circadian clock and ER homeostasis involving mutual regulation of each other 
(Pluquet et al., 2014). Moreover, SFAs such as palmitate induce ER stress via multiple 
mechanisms (Ariyama et al., 2010; Baldwin et al., 2012; Milanski et al., 2009) whereas 
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the omega-3 fatty acid DHA attenuates ER stress (Kolar et al., 2011). Because ER stress 
has been linked to inflammation in metabolic disorders (Cao et al., 2016), further studies 
are needed to determine whether ER stress plays a role in palmitate-mediated modulation 
of circadian timekeeping in parallel to, or perhaps in concert with, the inductive effects of 
this SFA on inflammatory signaling. 
The association between circadian clock dysfunction and metabolic disorders is 
largely based on studies that involve the complete disruption of rhythmicity using genetic 
or environmental approaches. However, the present data have novel implications for how 
differential and cell-specific modulation, rather than complete malfunction, of peripheral 
circadian clocks may be germane factors in the amplification of pro-inflammatory 
responses to HFD and SFA excess that are closely linked to systemic metabolic 
dysregulation. In both fibroblasts and differentiated adipocytes, palmitate-mediated 
inflammatory signaling is gated rhythmically and at times of peak induction, provides 
feedback that modulates the phase of the core clock mechanism. Because the phase-
shifting responses to palmitate appear to differ among peripheral cell types, this feedback 
modulation is likely to disrupt the local coordination of circadian timekeeping among cell-
autonomous clocks within a given tissue, thus further potentiating SFA-induced 
inflammation that contributes to systemic insulin resistance. The palmitate-induced 
inflammatory signals directly responsible for the feedback modulation of circadian phase 
remain to be determined, but future studies are warranted to examine the role of pro-
inflammatory cytokines such as IL-6 in mediating the phase-shifting effects of this SFA. 
Finally, these interactions between peripheral circadian clocks and pathways linking fatty 
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acid metabolism to tissue inflammation suggest that chronotherapeutic strategies using 
DHA and/or metformin, an AMPK agonist exploited in the treatment of hyperglycemia in 
type II diabetes (Akbar, 2003), may be critical in the management of metabolic diseases 
associated with fatty acid overload.  
 
  
 97 
 
CHAPTER V  
ROLE OF PROINFLAMMATORY CYTOKINES IN FEEDBACK MODULATION 
OF CIRCADIAN TIME KEEPING MECHANISM BY SATURATED FATTY ACIDS  
 
Introduction  
Circadian clocks in the SCN and peripheral tissues mediate the generation and 
entrainment of tissue- or cell-specific rhythms in physiological processes such as 
inflammation and metabolism (Richards and Gumz, 2012). While light-dark cues are the 
primary signals for circadian entrainment in mammals, nutrient metabolism and food 
intake, especially high fat diet (HFD), can modulate the circadian timekeeping function of 
SCN and peripheral clocks. HFD has been shown to alter the period of the activity rhythm 
and clock gene rhythms in peripheral tissues (Kohsaka et al., 2007a; Xu et al., 2014). In 
addition, recent findings indicate that HFD and the saturated fatty acid (SFA) palmitate, 
which is a major component of HFD, disrupt the diurnal patterns of glucagon like peptide 
1 and insulin secretion and damp clock gene rhythms in intestinal L-cells (Gil-Lozano et 
al., 2016). We have observed similar effects of HFD or palmitate on circadian clocks in 
vivo and in vitro; HFD and long-term treatment (48hr) with palmitate increased the period 
of activity rhythm and peripheral clock gene rhythms in vitro (Kim et al., 2016; Xu et al., 
2014), and acute (4hr) treatment of palmitate induced time-dependent phase shifts of 
peripheral clock gene rhythms (Kim et al., 2016). In view of increasing evidence for the 
association between circadian dysregulation and metabolic phenotypes, this diet-mediated 
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modulation of circadian clock function may contribute to the mechanism by which HFD 
and SFA induce systemic metabolic disorders.  
HFD and SFA are known to affect both the circadian system and metabolic 
homeostasis. However, it is unclear whether HFD- or SFA-induced circadian clock 
modulation and metabolic disorders are closely linked through a common mechanism. 
HFD and SFA initiate NF-kB- and JNK-mediated pro-inflammatory signaling cascades, 
leading to the release of pro-inflammatory cytokines such as IL-6 and TNFα (Fullerton et 
al., 2013). Therefore, it is possible that HFD-induced inflammatory signaling through pro-
inflammatory cytokines is a common mediator of diet-induced metabolic and circadian 
dysregulation. This speculation is indirectly supported by our previous observation that in 
HFD-fed mice and palmitate treated fibroblasts, the resulting increases in inflammatory 
signaling, including the induction of NF-kB and JNK activity and IL-6 expression, are 
coincident with corresponding alterations of circadian clock properties (Kim et al., 2016; 
Xu et al., 2014). Direct, evidence is provided by our previous findings that DHA and other 
inhibitors of inflammatory signaling (AICAR, cardamonin) attenuated palmitate-induced 
proinflammatory responses and phase shifts of the fibroblast clock (Kim et al., 2016). 
Furthermore, HFD has been shown to disrupt circadian rhythms of PPARγ and AMPK 
(Barnea et al., 2009; Eckel-Mahan et al., 2013), which are directly involved in the 
regulation of metabolism and may also link the clock machinery to mediators of 
inflammation. Collectively, these data suggest that inflammatory signaling may play a key 
role in the mechanism by which HFD or SFA dysregulates circadian time keeping in 
peripheral clocks. 
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The immune system is clock-regulated, but also feeds back to modulate the 
timekeeping function of circadian clocks. The modulatory effects of the immune system 
on circadian timekeeping and the underlying clock mechanism have been observed in 
studies demonstrating that lipopolysaccharide (LPS) administration induces phase shifts 
of the activity rhythm in mice (Marpegan et al., 2009) and represses SCN expression of 
the clock genes, Per2 and Dbp (Okada et al., 2008). Alterations in the functional properties 
of SCN and peripheral circadian clocks induced by LPS and other inflammatory stimuli 
such as HFD and SFA are presumably mediated through the release of pro-inflammatory 
cytokines. For example, intracerebroventricular injection of TNFα or IL-1β induces phase 
delays of circadian rhythm in locomotor activity at CT15 (Leone et al., 2012). Because 
our previous results demonstrate that the phase shifting responses to palmitate are 
associated with corresponding increases in IL-6 expression (Kim et al., 2016), our 
hypothesis is that the modulation of circadian phase (and period) in response to palmitate 
is derived from SFA-induced feedback on the clock mechanism via inflammatory 
signaling through pro-inflammatory cytokines. To test this hypothesis, we used two 
different approaches in this study: 1) we initially tested whether the pro-inflammatory 
cytokines, IL-6 and TNFα, mimic the phase shifting effects of palmitate at hour 12 when 
this SFA induces maximal phase shifts of the clock mechanism; and 2) conversely 
determined whether blockade of IL-6 or TNFα signaling using neutralizing antibodies 
abates palmitate-induced phase shifts in Bmal1-dLuc fibroblasts.  
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Material and Methods 
Cell culture: Bmal1-dLuc fibroblasts (Dr. Andrew Liu, University of Memphis, 
Memphis, TN; Ramanathan et al., 2012) were propagated on 60mm dishes in Dulbeco’s 
Modified Eagle Medium (DMEM; HyClone) containing 10% Fetal Bovine Serum (FBS) 
and maintained at 37°C and 5% CO2. Medium was replaced every 48hr and cultures were 
split 1:4 every 3 days.  
 
Fatty acid/drug preparation and treatment: Palmitate (Sigma) was dissolved in 
ethanol and then diluted (1:5.4 ratio) with 10% BSA (fatty acid-free and low endotoxin) 
diluted in 0.1M phosphate-buffered saline (PBS). Palmitate treatment in these studies was 
based on physiological concentrations that have been previously observed in vivo or used 
for in vitro studies (Ajuwon, and Spurlock, 2005; Han et al., 2010; Puri et al., 2009; 
Weldon et al., 2007). IL-6 recombinant protein (Invitrogen) was dissolved in 0.1M PBS, 
then diluted 1:100000 and 1:1000 in culture medium to achieve final concentration of 
0.1ng/ml and 10ng/ml, respectively. TNFα recombinant proteins (Invitrogen) and TNFα 
neutralizing antibodies (R&D systems) were dissolved in 0.1M PBS, then diluted 1:1000 
in culture medium to achieve final concentration of 20ng/ml and 0.4ug/ml, respectively. 
Vehicle controls for recombinant proteins and antibodies were treated with PBS and 
controls for fatty acid treatment were treated with BSA diluted in PBS with an equivalent 
ratio of ethanol. 
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Phase shifting effects of recombinant IL-6 and TNFα on the circadian clock: IL-6 
and TNFα recombinant proteins were used to test whether these proinflammatory 
cytokines mimic the phase shifting effect of palmitate. Bmal1-dLuc fibroblast cultures 
were exposed for 2hr to medium containing 15uM forskolin (hour 0) to facilitate circadian 
oscillation synchronization across cultures (Menger et al., 2007) and then treated for 4hr 
with IL-6 (final concentrations = 0.1ng/ml or 10ng/ml) at hour 12 when the phase shifting 
effects of palmitate are maximal (Kim et al., 2016). Parallel cultures were similarly treated 
with TNFα (final concentration = 20ng/ml) at 6hr intervals throughout the circadian cycle 
(i.e., hour 6, 12, 18 and 24). Vehicle controls for IL-6 and TNFα recombinant protein 
treatments consisted of cultures in which an equivalent amount of PBS was added to the 
medium. After treatment, all control and cytokine-treated cultures were placed in 
recording media for bioluminescence analysis of phase shifting effects on Bmal1-dLuc 
oscillations. 
 
Effect of neutralizing TNFα on palmitate-induced phase shifts of the circadian 
clock: Neutralizing antibody to TNFα were used to test whether inhibition of 
inflammatory signaling via these cytokines blocks or attenuates phase shifting effects of 
palmitate at hour 12 when this SFA induces maximal advances of the Bmal1-dLuc rhythm 
(Kim et al., 2016). Phase shifting responses were examined in Bmal1-dLuc fibroblasts 
treated with TNFα (0.4ug/ml) neutralizing antibody for 12hr in advance and during the 
4hr exposure to palmitate (250µM). The vehicle control for TNFα neutralizing antibody 
consisted of cultures in which an equivalent amount of PBS was added to the medium.  
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Real-time analysis of Bmal1-dLuc rhythms: Prior to bioluminescence analysis, 
growth medium including IL-6 and TNFα recombinant proteins, neutralizing antibodies, 
BSA and palmitate was removed. Cultures were rinsed, placed in DMEM recording 
medium containing 15uM forskolin, 25mM HEPES, 292µg/ml L-glutamine, 100units/ml 
penicillin, 100μg/ml streptomycin and 10uM luciferin (Promega) and then sealed airtight 
with sterile glass coverslips, and sterile silicon grease. The temporal patterns of Bmal1-
dLuc bioluminescence were analyzed using an automated 32-channel luminometer 
(LumiCycle; Actimetrics) housed in a standard culture incubator at 32°C. 
Bioluminescence from individual cultures was continuously recorded for ~70sec at 
intervals of 10min. Rhythm parameters were determined from baseline-subtracted data 
using the damped sine fit and Levenberg–Marquardt algorithm. The amplitude of phase 
shifts in response to treatment with IL-6, TNFα recombinant proteins or palmitate was 
determined by measuring the time difference between the peaks of the Bmal1-dLuc 
rhythms during the third cycle in PBS, BSA or BSA/vehicle (PBS) control and 
experimental treatment groups. 
 
Statistical analysis: Time-dependent differences in phase-shifting effects of TNFα on 
the Bmal1-dLuc rhythm were first analyzed by one-way analysis of variance (ANOVA). 
Paired comparisons between peak phase-shifting responses and the corresponding minima 
were analyzed post hoc for statistical differences using the Student Newman-Keuls 
sequential range test. The p-value was set at 0.05 for these post-hoc analyses. 
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Results 
Effect of recombinant IL-6 and TNFα on the circadian clock: Based on our previous 
results showing that the saturated fatty acid, palmitate treatment at hour 12 induces 
maximal phase shifts of Bmal1-dLuc rhythms along with coincidental induction of NF-B 
activation and IL-6 expression in fibroblasts in vitro, we first determined whether 
recombinant IL-6 mimics the phase shifting effects of palmitate at hour 12. Following to 
acute (4hr) treatment with 0.1ng/ml or 10ng/ml IL-6 at hour 12, the period of fibroblast 
Bmal1-dLuc rhythms was not significantly different from that observed in the PBS-treated 
control cultures. Phase shifting analysis revealed that the effects of IL-6 treatment were 
dose-dependent; 0.1ng/ml IL-6 induced small phase advances of about 0.5hr whereas 
10ng/ml IL-6 induced large phase advances of Bmal1-dLuc rhythms (≈1.5hr) that were 
comparable in amplitude to the phase shifts in response to acute palmitate treatment alone 
(Figure 26). In addition to IL-6, we next tested whether another pro-inflammatory 
cytokine, TNFα, also induces phase shifts of fibroblast Bmal1-dLuc rhythms. In contrast 
to the direction of the shifts induced by IL-6 and palmitate, acute treatment with 20ng/ml 
TNFα induced phase delays of Bmal1-dLuc rhythms in a time-dependent manner (Figure 
27). Peak phase-shifting responses to TNFα were observed at hour 12 when treatment 
induced large phase delays of ≈2.8hr (Figure 27B). TNFα treatment at hour 18 and 24 also 
induced phase delays albeit of reduced amplitude (≈0.5-0.9hr). At hour 6, TNFα had 
negligible effects on the Bmal1-dLuc rhythm. 
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Figure 26: Phase-shifting effects of acute IL-6 cytokine treatment on ensemble Bmal1-
dLuc rhythms in cultured fibroblasts. (A) Representative recordings of ensemble 
bioluminescence from individual cultures of Bmal1-dLuc fibroblasts treated for 4hr with 
PBS (control) (n=8), 0.1ng/ml IL-6 (n=8) or 10ng/ml IL-6 (n=8) at hour 12. Red arrow 
indicates time of PBS or IL-6 treatment. (B) Dose-dependent phase shifts (∆Φ) of 
fibroblast Bmal1-dLuc rhythms (mean ± SEM) in response to IL-6 treatment for 4hr. Mean 
(+SEM) phase shifts in hours are plotted at hour 12.   
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Figure 27: Phase-shifting effects of acute TNFα cytokine treatment on ensemble Bmal1-
dLuc rhythms in cultured fibroblasts. (A) Representative recordings of ensemble 
bioluminescence from individual cultures of Bmal1-dLuc fibroblasts treated for 4hr with 
PBS (n=8) or 20ng/ml TNFα (n=8) at hour 6, 12, 18 and 24. Red arrows indicate time of 
PBS or TNFα treatment. (B) Time-dependent phase shifts of fibroblast Bmal1-dLuc 
rhythms in response to TNFα treatment for 4hr. Mean (+SEM) phase shifts (∆Φ) in hours 
are plotted as a function of the timing of TNFα treatment (at hour 6, 12, 18 and 24). Phase 
delays of the fibroblast Bmal1-dLuc rhythm are indicated by negative values and advances 
are denoted by positive values. Asterisks indicate that peak phase-shifting responses to 
TNFα treatment at hour 12 were significantly greater (p<0.05) than those observed during 
the corresponding minima. 
  
 106 
 
Effect of neutralizing TNFα on palmitate-induced phase shifts of the circadian 
clock: In parallel with experiments using treatments with recombinant pro-inflammatory 
cytokines, we used the converse approach and determined whether neutralizing antibodies 
to TNFα that inhibit inflammatory signaling via this cytokine abate palmitate-induced 
phase shifts of fibroblast Bmal1-dLuc rhythms.  Treatment with neutralizing antibody to 
TNFα inhibited the phase-shifting responses to acute palmitate treatment at hour 12. In 
fibroblast cultures treated with neutralizing antibody to TNFα, palmitate-induced phase 
shifts of the Bmal1-dLuc rhythm were significantly decreased (p<0.05) relative to those 
observed in controls (Figure 28). Acute palmitate alone induced about 1.8 hour phase 
advances in PBS-pretreated controls whereas the amplitude of these shifts was reduced 
approximately by 50% following pretreatment with TNFα neutralizing antibody. 
Antibody treatment alone had little or no phase-shifting effect on the Bmal1-dLuc rhythm. 
 
Discussion 
HFD and SFAs modulate the timekeeping function of peripheral circadian clocks in 
mammals. Long-term and short-term HFD treatment have been shown to alter circadian 
properties (i.e., decrease amplitude, increase period, phase shift) of clock gene rhythms in 
peripheral tissues (Kohsaka et al., 2007a; Pendergast et al., 2013; Xu et al., 2014). In 
addition, several investigations, including our recent study, have demonstrated that the 
proinflammatory SFA, palmitate, also modulate circadian clock properties in liver, 
fibroblasts and hypothalamic cells (Greco et al., 2014; Kim et al., 2016; Tong et al., 2015).    
 107 
 
 
 
 
 
 
 
Figure 28: Effect of scavenging TNFα antibodies on palmitate-induced phase shifts of 
Bmal1-dLuc rhythms in cultured fibroblasts. Representative recordings of ensemble 
bioluminescence from individual Bmal1-dLuc fibroblast cultures treated with either PBS 
or TNFα antibody (0.4µg/ml) for 12hr in advance and during exposure to palmitate 
(250uM) for 4hr at hour 12. Phase-shifting effects of antibody treatment alone (with BSA) 
were also tested relative to control cultures. Red arrow denotes the time of palmitate 
administration after 12hr pretreatment with TNFα antibody (adjacent shaded area). Bar 
graphs depict the mean (±SEM) phase shifts (∆Φ) in hours as a function of treatment 
group. The asterisk indicates that palmitate-induced phase shifts were significantly 
decreased (p<0.05) in Bmal1-dLuc fibroblasts treated with TNFα antibody in comparison 
with those observed in controls (PBS+PAL). 
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Although the specific mechanism is unknown, recent findings suggest that inflammatory 
signaling may play a role in HFD and SFA modulation of the circadian timekeeping 
function of peripheral clocks. LPS treatment alters clock gene rhythms in peripheral 
tissues (Paladino et al., 2014; Shimizu et al., 2017) and our previous results demonstrate 
that various inhibitors of inflammation attenuate palmitate-induced phase shifts of 
fibroblast clock gene rhythms (Kim et al., 2016). The present data unveil the potential 
roles of proinflammatory cytokines in the feedback modulation of peripheral circadian 
clocks by HFD- and SFA-mediated inflammation; we found that treatment with 
recombinant IL-6 mimics the phase-shifting effects of palmitate on fibroblast circadian 
clocks whereas administration of neutralizing antibodies that scavenge TNFα attenuate 
phase-shifting responses to this SFA. Implications for TNFα in the pathway by which 
inflammation modulates circadian timekeeping are reinforced by studies demonstrating 
that TNFα alters liver and fibroblast clock gene rhythms (Cavadini et al., 2007) and that 
LPS-induced phase shifts are abolished in TNFα receptor-deficient (1/p55, Tnfr1) mice 
(Paladino et al., 2014). Collectively, these observations suggest that TNFα, IL-6 and other 
proinflammatory cytokines may be key elements in the signaling cascade by which HFD- 
and SFA-induced inflammation feeds back and modulates circadian properties of 
peripheral clocks.          
How proinflammatory cytokines like TNFα and IL-6 modulate the timekeeping 
function of peripheral circadian clocks is unknown. Recent evidence suggests that key 
mediators of inflammation may directly interact with core clock components and regulate 
clock gene expression. NF-κB is a major transcription factor that governs downstream 
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cytokine expression as well as the regulation of core clock components. The regulatory 
NF-κB subunit, RelB, has been shown to physically interact with BMAL1 and repress 
CLOCK/BMAL1-mediated circadian transcription in fibroblasts (Bellet et al., 2012). 
Furthermore, NF-κB also directly interacts with CLOCK protein (Spengler et al., 2012). 
Based on these observations, it is possible that elevated NF-κB levels may lead to 
increased binding with BMAL1 or CLOCK, perhaps modulating the clock mechanism by 
sequestering available binding partners and inhibiting the formation of BMAL1-CLOCK 
heterodimers during TNFα- and IL-6-induced inflammation in the current study. The role 
of cytokines in mediating communication between the immune system and circadian 
clocks is supported by studies demonstrating that cytokines themselves directly interact 
and regulate molecular components of the clock mechanism in peripheral tissues. For 
example, TNF treatment suppresses Per1-3 expression by direct inhibition of 
CLOCK/BMAL1-driven E-Box transactivation in fibroblasts (Cavadini et al., 2007). In 
addition, IL-6 induces Per1 gene expression in hepatoma cells (Motzkus et al., 2002). 
These findings have further implications for the role of proinflammatory cytokines in 
HFD- and SFA-mediated inflammatory feedback and its modulatory effects on the 
timekeeping function of peripheral clocks.  
Although our current results demonstrate that the proinflammatory cytokines IL-6 and 
TNFα induced phase shifts of fibroblast Bmal1-dLuc rhythms in a time dependent manner, 
it is unclear why the directionality of TNFα-induced shifts was different from those 
induced by IL-6 and palmitate treatment. It is noteworthy that another study using the 
same concentration of palmitate treatment, but longer treatment duration, yielded 
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concentrations of approximately 0.6ng/ml IL-6 and 0.05ng/ml TNFα in peripheral cell 
culture medium (Ajuwon and Spurlock, 2005). Since the TNFα concentration in our 
experiments (20ng/ml) was much higher than physiological concentrations observed in 
palmitate-treated cultures, it is possible that the observed effect is pharmacological, 
producing an increase in circadian period rather than the expected phase advance like 
palmitate. This possibility is indirectly supported by our published findings that long-term 
palmitate treatment increased the period of Bmal1-dLuc rhythm, but acute treatment with 
this SFA induced mainly phase advances of the fibroblast clock (Kim et al., 2016). 
Similarly, chronic HFD treatment induced robust increases in period of peripheral clock 
gene rhythms (Xu et al., 2014), whereas short-term consumption of HFD advanced the 
phase of liver circadian rhythms (Pendergast et al., 2013; Xu et al., 2014). Thus, future 
studies are warranted to examine the dose-dependent effects of TNFα on inflammatory 
signaling and circadian timekeeping in peripheral clocks. In addition, it will be important 
to further determine whether blockade of proinflammatory cytokines, or NF-κB and other 
key proinflammatory signals, provides resistance against HFD-induced circadian 
dysregulation and in turn its exacerbating effect on metabolic disorders.   
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CHAPTER VI  
GENERAL DISCUSSION AND CONCLUSIONS 
 
Circadian clocks in many peripheral tissues/cells of mammals coordinate daily 
rhythms in inflammatory responses, nutrient metabolism and secretion of hormones such 
as insulin and leptin that mediate the regulation of immune and metabolic homeostasis in 
response to immune challenge or overnutrition. However, increasing evidence strongly 
indicates that clock regulation of inflammatory and metabolic processes in peripheral 
tissues is not strictly unidirectional because inflammatory signals and nutrient metabolism 
feed back on peripheral clocks and modulate fundamental circadian properties. Thus, this 
dissertation focuses on mutual interactions between circadian clocks and key mediators of 
inflammation, along with their role in in linking diet-associated circadian dysregulation 
and metabolic phenotypes. 
 
Role of inflammatory signaling in circadian disruption- or desynchronization-
induced metabolic disorders 
HFD-induced obesity is associated with low-grade inflammation, which contributes to 
insulin resistance. Increasing evidence indicates that macrophages mediate diet-induced 
insulin resistance by stimulating proinflammatory signaling pathways in adipose tissue. 
Macrophage infiltration into adipose tissue is considered as the first step of chronic 
inflammation associated with HFD-mediated obesity. In conjunction with HFD-induced 
infiltration, adipose tissue macrophage polarization is shifted from an alternative anti-
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inflammatory M2 to a proinflammatory M1 status. Proinflammatory M1 activation results 
in increased macrophage production of proinflammatory cytokines such as IL-6 and TNFα 
(Fujisaka et al., 2009), leading to the induction of TLR4-mediated proinflammatory 
responses in adipose tissue. HFD-induced stimulation of TLR4, which is a pattern 
recognition receptor for innate immune responses, triggers downstream inflammatory 
signaling pathways via NF-κB and JNK activation, again resulting in proinflammatory 
cytokine expression in adipose tissue. Furthermore, AMPK is also involved in diet-
induced insulin resistance. In the presence of high cellular energy source such as HFD, the 
activity of this energy sensing enzyme is suppressed. Since AMPK inhibits NF-κB 
activation, the HFD-induced decrease in AMPK activity contributes to the pathogenesis 
of insulin resistance through the disinhibition of inflammation in diet-induced obesity 
(Salminen et al., 2011). Collectively, the elevated adipose tissue inflammation caused by 
macrophage proinflammatory activation in response to HFD mediates the development of 
metabolic disorders by interfering with insulin signaling and action. 
The studies described in this dissertation indicate that proinflammatory macrophage 
activation and the corresponding induction of inflammatory signaling are key processes 
in the mechanism by which circadian disruption or desynchronization exacerbate HFD-
mediated metabolic disorders (see below; Figure 29). Circadian desynchronization in 
response to chronic shifts of the LD cycle was observed to further amplify HFD-induced 
macrophage infiltration and M1 polarization in adipose tissue. Consistent with these 
observations, Xu et al. (2014) demonstrated that myeloid cell-specific disruption of the   
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Figure 29: Model of mechanism by which circadian disruption or desynchronization 
exacerbates HFD- or palmitate-mediated metabolic disorders. Circadian disruption or 
desynchronization decreases PPAR levels, thus amplifying diet-induced macrophage 
infiltration and M1 polarization in adipose tissue. Infiltrated M1 macrophages further 
potentiate HFD- or palmitate-mediated induction of NF-B and JNK activity and 
decreased AMPK activity, resulting in TNF and IL-6 expression. In turn, increased 
inflammation and fat deposition promotes systemic insulin resistance.  
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clock genes, Per1 and Per2, promotes adipose tissue macrophage infiltration and 
polarization to the proinflammatory M1 phenotype. PPARγ, which is required to maintain 
anti-inflammatory M2 macrophage activation (Odegaard et al., 2007b), may play a key 
role in mediating this clock disruption-associated shift in macrophage inflammatory status 
because the enhanced proinflammatory activation of Per1/2-disrupted macrophages was 
accompanied by decreased PPARγ levels and was reversed, at least in part, by PPARγ 
overexpression. Because the PPARγ promoter contains multiple E-boxes (Herzig et al., 
2003) and PPARγ is under circadian control in white adipose tissue (Yang et al., 2006), it 
is possible that circadian desynchronization in the present study may similarly amplify 
HFD-induced M1 macrophage activation by inhibiting PPARγ activity. Coupled with its 
amplification of M1 macrophage activation, circadian desynchronization potentiates 
inflammatory signaling in macrophages as exposure to chronic shifts in the LD cycle 
elevates LPS-stimulated IL-6, IL-1β and TNFα expression in macrophages from HFD-fed 
mice. Moreover, Per1/2 disruption similarly increases LPS-stimulated JNK1 and NF-B 
p65 phosphorylation and IL-1 and TNF expression in adipose tissue macrophages (Xu 
et al., 2014). Further implications for inflammatory processes in circadian 
desynchronization/disruption-induced metabolic dysregulation are manifested by the 
findings that exposure to shifted LD cycles and myeloid cell-specific disruption of Per1/2 
potentiated HFD-induced inflammation and concomitantly exacerbated insulin resistance 
and glucose intolerance. Altogether, these observations provide strong evidence that 
further amplification of macrophage proinflammatory is a key process in the physiological 
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cascade by which circadian desynchronization and disruption exacerbate diet-induced 
metabolic dysfunction. 
 
Role of HFD- and SFA-induced inflammation in the feedback modulation of 
circadian clock function 
Recent studies suggest that key mediators of inflammation have a strong influence on 
circadian clock properties. In this regard, data presented in this dissertation provide some 
insight into how HFD- and SFA-induced inflammation feed back on circadian clocks and 
modulate their timekeeping function (Figure 30). HFD induced a substantial increase in 
the period of macrophage clock gene rhythms. Consistent with our observations, Shi et al. 
reported that HFD feeding similarly lengthened the period of the Per2 rhythm in cultured 
adipose tissue (Shi et al., 2013b). This alteration of circadian clock properties may be 
caused by the activation of inflammatory signaling pathways because HFD-induced 
circadian dysregulation was associated with increased levels of LPS-stimulated JNK1 and 
NF-B p65 phosphorylation, as well as increased IL-6 and TNF expression in 
macrophages. The proinflammatory fatty acid palmitate, which is the most prevalent SFA 
in HFD, recapitulated the modulatory effects of HFD on fundamental properties of 
circadian clocks, whereas the anti-inflammatory fatty acid DHA had negligible effects on 
circadian period and phase. The opposing effects of proinflammatory versus anti-
inflammatory fatty acids further suggest that inflammatory signaling pathways may 
mediate HFD- and SFA-induced circadian dysregulation in peripheral tissues.  
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Figure 30: Model for the role of HFD- and SFA-induced inflammation in altering 
fundamental properties of peripheral circadian clocks. DHA blocks NF-κB-mediated 
inflammatory signaling pathway by activating AMPK. On the other hand, HFD and SFAs 
decrease AMPK activity and increase NF-κB activity, thus stimulating the production of 
proinflammatory cytokines (i.e. IL-6 and TNFα) in peripheral tissues. Increased IL-6 and 
TNFα levels feed back on circadian clock machinery and modulate its time keeping 
function.  
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Our study using acute palmitate treatment provides a better understanding how key 
components of inflammatory signaling pathways mediate HFD- and SFA-induced 
modulation of peripheral circadian clocks. Acute palmitate treatment induced time-
dependent phase shifts of clock gene rhythms, and the timing of the maximal phase shifts 
coincided with peak induction of NF-κB phosphorylation and IL-6 expression in 
fibroblasts and adipocytes. Because pharmacological inhibition of NF-κB repressed 
palmitate-induced phase shifts in fibroblasts, NF-κB activation may be a key signal in the 
cascade underlying HFD- and SFA-mediated circadian dysregulation. Similar to our 
observations, the phase shifting effect of LPS on circadian rhythms of locomotor activity 
is suppressed by NF-κB inhibition (Marpegan et al., 2005). As transmembrane receptors 
responding to fatty acids (Oh and Walenta, 2014), the pattern recognition receptor TLR4 
and GPR120 may be upstream elements of the mechanism by which palmitate-induced 
inflammatory signaling alters circadian properties of peripheral clocks. Because TLR4 is 
activated commonly by SFAs and its agonist LPS, leading to the induction of 
inflammatory signaling pathways via NF-κB (Wong et al., 2009), TLR4 may provide a 
critical mediator of palmitate-induced alterations of circadian clock function. 
Alternatively, it is possible that palmitate may decrease AMPK activity, leading to 
disinhibition of NF-κB, and in turn, to the alteration of circadian rhythms because AMPK 
activation was found to suppress palmitate-induced NF-κB activity and phase shifts. The 
inhibitory effect of DHA on palmitate-induced NF-κB activity and phase shifts further 
supports this possibility because DHA increases AMPK activity in macrophages via G-
protein coupled receptor GPR120 (Xue et al., 2012).   
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Current evidence indicating that IL-6 treatment mimics the phase shifting effects of 
palmitate and scavenging TNFα using a neutralizing antibody attenuates palmitate-
induced phase shifts, it is speculated that proinflammatory cytokines themselves may 
directly feed back on the clock mechanism during HFD- and SFA-induced inflammation. 
In conjunction with other studies demonstrating that TNFα phase shifts the circadian 
rhythms of locomotor activity in vivo and PER2 levels in cultured SCN astrocytes in vitro 
(Leone et al. 2012), our observation provides primary evidence that HFD- and SFA-
induced inflammatory signaling via NF-κB and proinflammatory cytokines plays a critical 
role in the feedback modulation of circadian timekeeping in peripheral clocks. 
 
Role of mutual interactions between inflammatory signaling and circadian clocks in 
diet-induced metabolic disorders  
All data presented in this dissertation point to key mediators of inflammation and 
inflammatory signaling as the central hub linking diet-mediated circadian dysregulation 
and metabolic dysfunction (Figure 31). HFD and SFAs activate the NF-κB-mediated 
inflammatory signaling pathway directly or indirectly through inhibition of AMPK 
activity in peripheral tissues. The transcription factor NF-κB promotes proinflammatory 
responses by inducing the production of cytokines such as TNFα and IL-6, thus 
exacerbating diet-related insulin resistance and glucose intolerance. In parallel, NF-κB-
mediated inflammatory responses modulated circadian clock properties through 
proinflammatory cytokines. Disrupted or desynchronized circadian rhythms amplified 
HFD- and SFA-induced macrophage M1 polarization and infiltration into adipose tissue,  
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Figure 31: Model for the role of mutual interactions between inflammatory signaling and 
circadian clocks in diet-induced metabolic disorders. HFD- and SFAs-induced 
inflammation feed back on the clock mechanism and modulate fundamental properties of 
circadian rhythms in peripheral tissues. In turn, this circadian dysregulation further 
amplifies HFD- and SFAs-mediated inflammation, and exacerbates diet-induced systemic 
insulin resistance and glucose intolerance.  
 
 
  
HFD/SFAs 
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perhaps by repressing macrophage PPARγ expression, and then exacerbated NF-κB-
mediated proinflammatory responses in adipose tissue. In turn, this dysregulation of 
circadian clock function exacerbates diet-induced insulin resistance. This amplification of 
HFD- and SFA-induced immune responses may exacerbate systemic insulin resistance 
and glucose intolerance, thus implicating circadian dysregulation in the pathogenesis of 
diet-induced metabolic disorders. Taken together, our study suggests that mutual 
interactions between inflammatory signaling pathways and circadian clocks may govern 
the effects of HFD and SFAs on metabolism. 
 
Remaining Questions and Concluding Remarks 
The studies in this dissertation have yielded novel evidence for the role of key 
mediators of inflammation in diet-induced circadian modulation and pathogenesis of 
metabolic disorders. We have shown that circadian desynchronization in response to 
shifted LD cycles was accompanied by amplification of diet-induced inflammatory 
responses and increased severity of insulin resistance and glucose intolerance. However, 
these observations are correlative in nature so it remains unclear whether circadian 
desynchronization-associated exacerbation of proinflammatory responses was directly 
responsible for the elevations in insulin resistance and glucose intolerance. To address this 
issue, it will be necessary to test the effects of various inflammatory inhibitors on 
metabolic phenotypes in mice exposed to chronic shifts of the LD cycle. The AMPK 
activator, AICAR, metformin which has been used to treat diabetes in humans, and the 
PUFA DHA are optimal for this analysis due to their well-established anti-inflammatory 
 121 
 
effects. If amplified proinflammatory signaling directly mediates the effects of circadian 
dysregulation in increasing the severity of insulin resistance and glucose intolerance, then 
treatment with AICAR, metformin, DHA or other inhibitors of inflammatory responses 
should “rescue” metabolic function in animals on shifted LD cycles. Because PPARγ is a 
key upstream mediator of anti-inflammatory macrophage activation (Odegaard et al., 
2007b) and myeloid cell-specific Per1/Per2 disruption decreased macrophage PPARγ 
levels in conjunction with increased proinflammatory M1 activation and systemic insulin 
resistance (Xu et al., 2014), future studies are also warranted to examine the role of PPARγ 
in the signaling cascade by which circadian dysregulation exacerbates diet-induced 
macrophage infiltration and M1 activation, inflammatory signaling and metabolic 
phenotypes. If macrophage levels of PPARγ are suppressed in response to chronic shifts 
of the LD cycle similar to those observed in Per1/2-disrupted macrophages, then treatment 
with a PPARγ activator such as rosiglitazone should reverse the circadian dysregulation-
associated increases in proinflammatory macrophage activation and cytokine production, 
thus ameliorating diet-induced metabolic alterations.  
In Chapter II, IV and V, our experiments have yielded some insight into the 
mechanism by which HFD and SFAs modulate peripheral circadian clocks. Although the 
results of these studies directly implicate AMPK, NF-κB and cytokines in the HFD- and 
palmitate-induced modulation of peripheral circadian clocks, there are other critical 
components of inflammatory signaling pathways, such as TLR4, that also deserve some 
consideration. TLR4 is a transmembrane receptor that recognizes HFD and SFAs and 
initiates intracellular proinflammatory signaling cascades in peripheral tissues. Because 
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of its role in gating diet-induced inflammation as an upstream element of NF-κB, it would 
be interesting to test whether TLR4 inhibitors block the effects of HFD and palmitate on 
circadian clock properties (i.e., period or phase). Furthermore, G-protein coupled receptor 
GPR120 would be another interesting upstream target in future studies because it mediates 
the anti-inflammatory effect of DHA in macrophages via AMPK activation (Xue et al., 
2012). Like a DHA treatment in our study, GPR120 activators (i.e., Grifolic acid and GSK 
137647) would be expected to attenuate HFD- and palmitate-induced circadian 
dysfunctions. Similarly, the effect of PPARγ activators and inhibitors are other drugs to 
be tested in future studies because it regulates lipid metabolism and inflammatory 
responses in response to HFD and fatty acids. Based on the fact that PPARγ is a target of 
many anti-diabetic drugs due to its anti-inflammatory effects (Martin, 2010), a PPARγ 
inhibitor would be expected to mimic the modulatory effect of HFD and SFAs on circadian 
clocks, while a PPARγ activator would be expected to ameliorate HFD- and SFA-induced 
circadian dysregulation.  Since PPARγ is under circadian control in adipose tissue (Yang 
et al., 2006), PPARγ inhibitors and activators would be expected to have time-dependent 
effects of circadian rhythms.  
The research described here has established the feedback modulation of circadian 
clocks by HFD- and palmitate-induced inflammation, but one intriguing question that 
remains unanswered is how/why are these nutrient-related modulatory effects more robust 
on peripheral clocks than on the SCN clock? In our in vivo study, it is possible that HFD 
and palmitate had greater effects on peripheral clock oscillations than on SCN clock-
regulated rhythms because HFD and palmitate are processed and metabolized by 
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peripheral tissues first. To investigate this possibility, it will be necessary to test the effects 
of palmitate microinjections into SCN on circadian period or phase of the activity rhythm. 
Since HFD- and SFA-induced macrophage inflammation is the key signaling pathway in 
feedback modulation of circadian clocks, it will need to be determined whether peripheral 
treatment of palmitate would have a greater effect on inflammatory responses in adipose 
tissue macrophages than on microglia (the resident macrophages in brain). Given the 
circadian control of immune responses, it would be also interesting to test whether 
peripheral or central treatment of palmitate alters the fundamental properties of circadian 
rhythms in microglia. 
In summary, the research described here suggests that inflammatory mediators may 
play a key role in the underlying mechanism by which HFD and SFAs modulate 
fundamental properties of circadian clocks, and in turn this circadian dysregulation 
exacerbates diet-induced systemic insulin resistance and glucose intolerance. Our findings 
provide possible therapeutic targets for metabolic disorders during circadian disruption, 
or desynchronization (i.e., shift work), and serves as a foundation for further studies to 
examine interactions between metabolism, the circadian clock, and immune systems.  
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